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RESUMO  
O yacon (Smallanthus sonchifolius), raiz andina, tem se destacado pelo seu potencial 
prebiótico devido aos elevados teores de frutooligossacarídeos (FOS) e inulina em sua 
composição. O objetivo deste trabalho foi verificar se a alimentação com yacon alteraria o 
sistema imune de camundongas BALB/c e se sua ingestão regular seria capaz de modular a 
resposta intestinal induzida pela instilação retal de ácido trinitrobenzeno sulfônico (TNBS). 
Para avaliar os efeitos do consumo regular de yacon sobre o sistema imune murino, 
camundongas BALB/c com oito semanas de idade foram divididas em quatro grupos 
experimentais alimentados por trinta dias com dieta: controle AIN-93M; 5% de FOS 
comercial; 3% e 5% FOS de yacon. O peso corporal e consumo da ração foram 
acompanhados semanalmente. Os níveis de anticorpos IgA, IgM, IgG séricos e IgA fecal,  a 
produção de óxido nítrico (NO) por macrófagos, a frequência de linfócitos T e B 
sanguíneos e a proliferação de células esplênicas in vitro foram avaliados. Para avaliar o 
efeito do consumo regular de yacon sobre a colite experimental, metade dos animais que 
ingeriram as dietas teste foi instilada por via retal durante sete dias consecutivos com 
solução contendo TNBS, enquanto que o restante recebeu veículo (etanol). Foram 
analisados o peso corpóreo, histopatologia dos intestinos, bem como a proliferação de 
células esplênicas e dosagem de citocinas. Os animais alimentados com yacon 
apresentaram respostas semelhantes aos camundongos que ingeriram as demais dietas em 
relação ao ganho de peso, consumo de ração, níveis de anticorpos séricos, frequência de 
linfócitos T e B sanguíneos e produção de NO por macrófagos. Entretanto, observou-se um 
aumento significativo tanto na secreção de IgA fecal quanto na proliferação de células 
esplênicas de animais alimentados com yacon. Os camundongos alimentados com yacon 
 xxii 
 
sofreram menor perda de peso após instilação com TNBS do que os animais alimentados 
com AIN93M e FOS. Os animais que consumiram yacon apresentaram intestinos íntegros e 
funcionais, oposto ao observado nos animais dos demais grupos. Não foram encontradas 
diferenças significativas na proliferação de células esplênicas e produção de citocinas entre 
os diferentes grupos, salvo a maior produção de IL-17 e menor secreção de IL-10 nas 
culturas de células de animais alimentados com FOS. Nossos dados indicam que o 
consumo regular de yacon não acarreta efeitos adversos à fisiologia e sistema imune 
murino, levando à melhora no quadro de colite induzida por instilação com TNBS.  
Palavras-chave: Prebióticos, Frutooligossacarídeos (FOS), Yacon, TNBS-colite, Sistema 
imune.
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ABSTRACT 
Yacon (Smallanthus sonchifolius), Andean root, has been recognized for its prebiotic 
potential due to its high levels of fructooligosaccharides (FOS) and inulin. The objective of 
this study was to verify if the regular consumption of yacon alters the immune system of 
BALB/c mice and if it may modulate intestinal inflammation induced by the rectal 
instillation of trinitrobenzene sulfonic acid (TNBS). To evaluate the effects of regular 
yacon consumption on the murine immune system, eight-week-old BALB/c mice were 
divided into four experimental groups fed for thirty days with diet: control AIN-93M, 5% 
commercial FOS, or 3% or 5% yacon FOS. Body weight and food consumption were 
monitored weekly. The serum levels of IgA, IgM and IgG and fecal IgA, the nitric oxide 
(NO) production by macrophages, the frequency of T and B lymphocytes in the blood and 
the proliferation of spleen cells (in vitro) were evaluated. To evaluate the effects of regular 
yacon consumption on experimental colitis, half of the animals was instilled rectally with a 
solution containing TNBS for seven consecutive days while the rest received vehicle 
(ethanol). We analyzed the body weight, histopathology of the intestines, spleen cell 
proliferation and cytokine production. The animals fed yacon showed responses similar to 
mice that consumed the other diets in relation to weight gain, food intake, serum antibody 
levels, frequencies of T and B lymphocytes in the blood and NO production by 
macrophages. There was a significant increase in both fecal IgA secretion and the 
proliferation of spleen cells from animals fed yacon. The mice fed yacon suffered less 
TNBS-induced weight loss than animals fed the FOS and AIN93M diets. The animals that 
consumed yacon also showed intact and functional intestines, as opposed to the other 
groups of animals. There were no significant differences in spleen cell proliferation or 
 xxiv 
 
cytokine production among groups, except for the increased production of IL-17 and lower 
IL-10 secretion in the cultures of cells from animals fed FOS. Our data indicate that the 
regular consumption of yacon does not cause adverse effects on the physiology or the 
murine immune system and that yacon consumption ameliorates colitis induced by TNBS 
instillation.  
Keywords: Prebiotics, Fructooligosaccharides (FOS), Yacon root, TNBS-colitis, Immune 
system.
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INTRODUÇÃO GERAL 
A preocupação com uma alimentação mais adequada e a procura pelo bem-estar tem 
direcionado as pesquisas para a busca de alimentos que, além de fornecer nutrientes, 
possam trazer benefícios à saúde humana e à qualidade de vida. A alimentação é um fator 
importante no desenvolvimento e prevenção de diversas doenças. O aumento na incidência 
de doenças crônicas e degenerativas é mais um estímulo à investigação por alimentos com 
potencial terapêutico e preventivo. Nesse sentido, os alimentos funcionais oferecem uma 
grande oportunidade de se obter uma alimentação saudável (ORGANIZACIÓN 
PANAMERICANA DE LA SALUD (OPS), 2007; WATZL et al., 2005). 
Os alimentos funcionais são aqueles que, além das funções nutricionais básicas, 
provocam efeitos benéficos, tanto metabólicos e/ou fisiológicos, à saúde (ANVISA, 2005). 
Entre os alimentos funcionais se incluem aqueles com propriedades prebióticas. Para um 
alimento ser considerado prebiótico, ele deve se ajustar aos seguintes critérios: 1) 
resistência à acidez gástrica; 2) ser fermentado pela microbiota intestinal; 3) estimular 
seletivamente o crescimento e/ou a atividade de bactérias intestinais associadas com saúde 
e bem-estar (GIBSON et al., 2004). 
Os oligossacarídeos não digeríveis (NDOs, do inglês non-digestible 
oligosaccharides), constituem um grupo de prebióticos encontrados em plantas e vegetais 
como compostos de reserva energética. O consumo de prebióticos provoca a modulação de 
funções fisiológicas-chaves como a absorção de cálcio, o metabolismo de lipídios, assim 
como a modificação da microbiota intestinal para um padrão mais adequado 
(ROBERFROID, 2005). 
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O crescimento de bactérias benéficas de tipo Bididobacterium e Lactobacillus 
decorrente do consumo de prebióticos (efeito bifodogênico) inibe o desenvolvimento de 
espécies bacterianas tanto putrefativas quanto patogênicas na região intestinal (POOL-
ZOBEL et al., 2002). Os metabólitos de probióticos e a produção de ácidos graxos de 
cadeia curta por bifidobactérias estimulam a absorção de cálcio, o metabolismo de lipídios 
e a modulação das respostas imunes associadas à mucosa intestinal (ROBERFROID, 2005).  
O Yacon (Smallanthus sonchifolius), raiz andina, é uma fonte potencial de 
prebióticos de tipo FOS e inulina (GRAEFE et al., 2004). Alguns estudos têm avaliado os 
efeitos benéficos do consumo de yacon como fonte de FOS em humanos e animais de 
experimentação. Recentemente, foi demonstrado que ratos diabéticos alimentados com 
farinha de yacon apresentaram redução significativa nos níveis séricos de colesterol LDL, 
contrastando com os animais alimentados com ração comum. Os resultados obtidos 
denotam o potencial hipolipidêmico do consumo de yacon em situações de alteração 
metabólica, como no diabetes (HABIB et al., 2011). Genta e colaboradores (2009) também 
demonstraram que o consumo de xarope de yacon por mulheres em fase pré-menopausa 
reduziu o índice de massa corporal e os níveis de LDL comparados com as pacientes que 
ingeriram placebo. Por conta de seus atributos prebióticos, o consumo de yacon pode ser 
capaz de modular as respostas imunes inflamatórias, especialmente as que ocorrem em 
nível intestinal. 
A doença intestinal inflamatória, mais conhecida por sua sigla de origem inglesa IBD 
(Inflammatory bowel disease), é uma condição inflamatória observada em humanos 
geneticamente predispostos. Embora a causa não seja totalmente esclarecida, a IBD está 
associada às alterações na função da barreira intestinal, que incluem a redução da expressão 
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de proteínas de junção e aumento de apoptose das células epiteliais intestinais. Tais 
alterações são causadas por antígenos do lúmen derivados de bactérias não patogênicas que 
entram em contato com células do sistema imunológico da camada mucosa subjacente 
(HELLER et al., 2005; SCHULZKE et al., 2006).  
A IBD pode ser considerada uma doença auto-imune cuja manifestação é vista como 
uma resposta imune anormal da mucosa aos antígenos da microbiota que são normalmente 
tolerados, dada sua proximidade e persistência (STROBER et al., 2002). Em uma situação 
de normalidade, as células T são ativadas e expandidas de modo polarizado (Th1, Th2, 
Th17) para destruir e proteger contra a invasão de patógenos entéricos no intestino. 
Contudo, quando este processo não é devidamente regulado, as células efetoras entéricas 
podem promover uma inflamação intestinal crônica (KOBOZIEV et al., 2010). Nesse 
sentido, a origem dos sintomas da colite resulta em uma resposta imune desequilibrada, 
com produção exacerbada de citocinas inflamatórias (BOUMA, STROBER, 2003). 
A Doença de Crohn e a Colite Ulcerativa são as duas principais formas clinicamente 
definidas de IBD. Elas apresentam condições inflamatórias progressivas ou crônicas 
remitentes que afetam o trato gastrointestinal e a mucosa do cólon e estão associadas ao 
aumento de risco de câncer de cólon (KASER et al., 2010). 
É conhecido que diversas substâncias naturais favorecem os processos envolvidos na 
imunidade. Contudo, a literatura carece de informações acerca dos possíveis benefícios 
decorrente do consumo regular de yacon sobre o sistema imune. Nesse sentido, o objetivo 
do presente estudo foi verificar se a ingestão de yacon altera o sistema imune de 
camundongas BALB/c, e se seu consumo regular é capaz de modular a inflamação 
intestinal induzida pela instilação retal de ácido trinitrobenzeno sulfônico (TNBS). 
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A presente tese está dividida em cinco capítulos na forma de artigos científicos. Os 
capítulos um, dois e três correspondem às revisões bibliográficas acerca dos efeitos 
benéficos do consumo de prebióticos, frutanos e yacon. O capítulo quatro apresenta os 
resultados a respeito dos efeitos do consumo regular de yacon sobre o sistema imune de 
camundongas BALB/c. No capítulo cinco estão expostos os resultados do efeito do 
consumo regular de yacon sobre o curso da colite induzida em camundongas BALB/c pela 
administração de TNBS. Ao final, são apresentadas as conclusões gerais e as sugestões de 
pesquisas futuras. 
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Abstract 
The gradual increase of degenerative diseases observed in the last decades has been 
raising morbidity, incapacitation and mortality. The occurrence of these kinds of diseases is 
related to the aging of humanity as well as the unhealthy choices of individuals, particularly 
those dwelling in large urban centers, which are closely linked with poor nutrition, obesity, 
and tobacco and alcohol consumption. The introduction of functional compounds in the diet 
seems to be an attractive alternative to ameliorate the quality of life of all age groups. The 
prebiotics stand out because of their beneficial effects, favoring the growth of colonic 
microbiota, helping the gastrointestinal metabolism, and regulating the serum cholesterol 
and mineral absorption. Experimental data indicates that prebiotics could reduce the 
severity or incidence of degenerative diseases, such as neoplasias, diabetics, coronary 
diseases, and infectious diseases. They also seem to promote a positive modulation of the 
immune system. Their effects on the immune system could even be associated to increase 
of resistance to infection and microbicide capability, as well as to decrease in allergic 
reactions. This article's goal is to analyze the immunomodulatory potential of prebiotics 
observed in experimental and trial studies. 
Keywords: Prebiotics, Bifidogenic effect, Immunomodulation, Immune disorders. 
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1. Introduction 
In recent years, poor eating habits have had a pronounced impact on our health and 
quality of life. The excessive consumption of fats, especially saturated fats, surplus sugar 
and salt and low consumption of resistant starch and dietary fibers have led to a raised 
incidence of chronic degenerative diseases, such as cardiovascular problems, cancer, 
diabetes, and obesity ([OPS] Organización Panamericana de la Salud (OPS), 2007).  
However, all around the world there is a growing interest on functional foods, that is, 
foods containing compounds benefiting physiological activities and strengthening the 
immune system, acting in the prevention and reduction of degenerative diseases (Watzl, 
Girrbach, & Roller, 2005).  
The modulation of the immune system resulted from the ingestion of functional foods 
is a striking strategy for optimizing immunity and, consequently, improving health. The 
food components which have been most evaluated in immunonutrition research are the fatty 
acids omega-3, amino acids (arginine, taurine, glutamine, and cysteine), micronutrients 
(selenium, zinc), prebiotics, and probiotics (López-Varela et al., 2002; Singh, Gopalan, & 
Sibal, 2002; Choque-Delgado, Tamashiro, & Pastore, 2010). 
Probiotics are live microorganisms, which confer beneficial effects to the host when 
administered in adequate amounts (FAO/WHO, 2001). The most studied genera are 
Bifidobacterium and Lactobacillus. The bacteria producing lactic acid, such as Lactococcus 
and Streptococcus could also be included in this group. Other promising probiotics include 
the genera Bacillus, Bacteroides, Enterococcus, Escherichia, Faecalibacterium, 
Propionibacterium, and the Saccharomyces yeast (Preidis & Versalovic, 2009).  
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Prebiotics are the functional compounds of foods, which play an important role on the 
prevention and treatment of gastrointestinal diseases. Prebiotics consumption could result 
in some advantages to the host, due to their selective metabolism in the intestinal tract 
(Gibson, Probert, Van Loo et al., 2004). The metabolites produced by healthy microbiota 
interact with the immune system in the prevention or reduction of intestinal inflammatory 
diseases (Damaskos & Kolios, 2008).  
Products containing a mixture of probiotics and prebiotics are called synbiotic. They 
have the potential of promoting the survival and increasing the function of the probiotics 
and beneficial microorganisms residing in the microbiota. It has been demonstrated that the 
consumption of synbiotics could be responsible for alterations on the composition of 
microbiota in a more effective way when compared to the ingestion of probiotics alone 
(Gibson & Roberfroid, 1995; Preidis & Versalovic, 2009).  
The food industry, mindful of these results, is already accruing value of their products 
by supplementing them with prebiotics. To understand what the actual beneficial properties 
of these compounds are and how they can improve human health, in this work we will 
evaluate the literature concerning the immunomodulatory effects of the intake of prebiotics, 
both in experimental models and in humans. 
 
2. Prebiotics 
In order for a food component to be considered a prebiotic, it must meet the following 
criteria: (1) resists gastric acidity; (2) is fermented by the intestinal microbiota; 3) 
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stimulates selectively the growth and/or activity of intestinal bacteria associated with health 
and wellbeing (Gibson et al., 2004).  
Most of the studies about prebiotics have been focused on fructans, such as inulin, 
fructooligosaccharides (FOS) and galactooligosaccharides (GOS), which are manufactured 
at relatively low cost, since they can be extracted from plants or produced by enzymatic 
synthesis. They are also valuable functional ingredients for the food industry with the 
potential to improve the sensory properties of food (Macfarlane, Macfarlane, & Cummings, 
2006; Macfarlane, Steed, & Macfarlane, 2007). Fructans are found as reserve carbohydrates 
in plant species. The occurrence of these sugars in vegetables is scant as compared to that 
of starch (De Carvalho & Figueiredo-Ribeiro, 2001).  
Fructans are found in almost every species in the Asteraceae family, many of which 
show economic importance, such as cichorium (Cichorium intybus) and Jerusalem 
artichoke (Helianthus tuberosus) (Carabin & Flamm, 1999; Figueiredo-Ribeiro, 1993). 
Fructans are composed of one or as many as 70 units of fructose linked or not linked 
to a terminal sucrose molecule. Fructans can show a linear or ramified structure, with 
molecules united by frutosil–fructose bonds of type β(2→6), found in fructans of levan 
type, or β(2→1) bonds, which are found in inulin type fructans (Fig. 1a) (Carabin & 
Flamm, 1999; Roberfroid, Gibson, & Delzenne, 1993). Through enzymatic reactions, 
inulins give rise to FOS and oligofructoses. FOSs are non-digestible oligosaccharides 
(NDOs) and are considered non-caloric agents, since they are resistant to the hydrolytic 
action of digestive enzymes. 
Upon reaching the colon, the FOSs are degraded by intestinal bacteria such as 
bifidobacteria, which produces short-chain fatty acids (SCFA) such as acetate, propionate, 
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and butyrate, as well as lactic acid, carbon dioxide, and hydrogen (Luo et al., 1996; 
Roberfroid et al., 1993). They play a very important role in health as a bifidogenic agent, 
regulating gastrointestinal tract, improving lipid metabolism, and increasing mineral 
absorption. They also reduce glucose levels of diabetics, modulate the immune system, 
decrease incidence of colon cancer and synthesis of triglycerides, among others (Kaur & 
Gupta, 2002; Kruger, Brown, Collet, Layton, & Chollum, 2003; Passos & Park, 2003, 
Thakur & Kumar, 2008). 
GOS is present in human milk, which contains various oligosaccharides originating 
from lactose (Macfarlane et al., 2007). GOSs are mainly produced using lactose from milk 
serum after protein removal. In this way, GOS constitutes a byproduct of the dairy industry 
(Macfarlane et al., 2007). The GOS is mainly obtained by the action of β-galactosidase on 
lactose, resulting in the production of a lactose molecule with one or more galactosil 
residues linked by β1-3, β1-4 and β1-6 (Fig. 1c). The β-galactosidase acts as a hydrolytic 
enzyme and also as a condensation enzyme, in this case, for a transglycosylation reaction 
(Gibson, 2008; Rabiu, Jay, Gibson, & Rastall, 2001; Sako, Matsumoto, & Tanaka, 1999; 
Santos, Simiqueli, & Pastore, 2009). Others substances classified as prebiotics are 
lactulose, Xylooligosaccharides (XOS) and mannanoligosaccharides (MOS).  
Lactulose (4-0-β-D-galactopyranosyl-D-fructofuranose) is a disaccharide composed 
of galactose and fructose, found in milk and milk products which undergo thermal 
treatments, used in the baby food and pharmaceutical industries (Fig. 1b) (Saron, Sgarbieri, 
& Lerayer, 2005; Schumann, 2002). It can be used as a laxative, for preventing and treating 
chronic constipation, portal systemic encephalopathy, and other hepatic or intestinal 
disorders (Holsinger, 1999).  
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Xylooligosaccharides (XOS) are sugar oligomers formed by units of xylose found 
naturally in fruit, vegetables, milk, and honey (Fig. 1d). Its industrial production is carried 
out through lingo cellulosic materials. XOS can be used for various purposes, among which 
applications in the foods and pharmaceutical industries. Its ingestion favors the selective 
growth of Bifidobacterium spp which regulates intestinal functions. Moreover, XOS are 
moderately sweet, stable over a wide range of pH and temperatures and have organoleptic 
characteristics suitable for incorporation into foods (Alonso, Domínguez, Garrote, Parajó, 
& Vázquez, 2003). Trials with human subjects show that XOS can be considered as 
prebiotic and benefits the intestinal microbiota (Menezes & Durrant, 2008).  
Mannanoligosaccharides are obtained from the cell walls of yeast (Saccharomyces 
cerevisiae). They not only promote the balance of the microbiota but also have 
immunomodulatory properties (Ferket, 2004). 
The health promoting effects of prebiotics include its contribution to the nutrition of 
the host, inhibition of the growth of potential pathogens and promotion of beneficial 
microbiota. The latter causes fermentation of non-digestible fibers, energy saving, synthesis 
of B and K vitamins, metabolism of plant compounds and pharmaceuticals, production of 
SCFA and polyamines, improvement in gastrointestinal motility and function, cholesterol 
reduction, and stimulation of the local immune system (Hidaka, Eida, Takizawa, Tokunaga, 
& Tashiro, 1986; Penders et al., 2006; Shadid et al., 2007). 
 
3. The immunomodulatory effect 
Prebiotics act like growth factor to particular commensal bacteria, which inhibit the 
adherence and invasion of pathogens in the colonic epithelia by competing for the same 
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glycoconjugates present on the surface of epithelial cells, altering the colonic pH, favoring 
the barrier function, improving the mucus production, producing short-chain fatty acids and 
inducing cytokine production (Fig. 2) (Korzenik & Podolsky, 2006; Walker, 2000). The 
gut-associated lymphoid tissue (GALT) is the biggest tissue in the immune system 
comprising 60% of all lymphocytes in the body. It contains Peyer's patches (PP), lamina 
propria (LP) and intraepithelial lymphocytes (IEL) forming a unique immune network 
(Iijima, Takahashi, & Kiyono, 2001; Mowat & Viney, 1997). PP contains follicle-
associated epithelium (FAE) that covers M-cells responsible for transporting the antigen 
onto the lymphatic tissue where dendritic, T and B-cells are found. Activated lymphocytes 
in the PP are drained to and expand in the mesenteric lymph nodes and transit through the 
blood stream into mucosal sites (Mowat, 2003). LP is the region between the epithelium 
and the muscle and contains mast cells, dendritic cells, macrophages and B- and T-cells 
(MacDonald, 2003).  
The establishment of normal microbiota is fundamental for the development of the 
immune system. In germ-free animals, for example, there is a dramatic reduction in the 
number and function of lymphocytes in both the GALT and spleen and peripheral lymph 
nodes. In general, the host tolerates the presence of microorganisms that form the normal 
microbiota, developing an immune response in which elements such as regulatory T cells 
(Treg), Th1 and Th17 are present in a balanced manner resulting in a state of “physiological 
inflammation” (Sansonetti, 2011). Lymphocytes that were initially activated in GALT 
express addressins that direct them to other mucosal sites, such as salivary gland, mammary 
gland, cervix vagina uterus, and bronchus lymphoid associated tissue, composing the 
common mucosal immune system (Kaufman & Barouch, 2009). Thus, modulation of the 
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microbiota at the gastrointestinal tract by prebiotics and probiotics has a broad influence on 
the immune response of the host. 
Several studies have highlighted the importance of intraluminal bacteria in 
maintaining the integrity of intestinal mucosa by modulating the inflammatory process in 
this microenvironment. Recent studies have associated certain compositions of intestinal 
bacteria with severe acute pancreatitis, including depletion of beneficial intestinal bacteria 
such as lactobacillus and colon proliferation of pathogens (reviewed by Hegazi, 2010). As 
discussed by these authors, a recent trial study showed that supplementation of isocaloric 
and isonitrogenous jejunal feeding with the high dose of prebiotics mix (insoluble and 
soluble fibers) improved clinical outcome and dampened systemic inflammatory disease in 
patients with severe acute pancreatitis (Karakan, Ergun, Dogan, Cindoruk, & Unal, 2007), 
although there was no data on the effects of prebiotics supplementation on the composition 
of the intestinal microbiota. 
The administration of prebiotics has been associated with immunomodulatory effects 
encompassing innate, adaptive immunity as a result of the interaction with the microbiota 
(Vulevic, Drakoularakou, Yaqoob, Tzortzis, & Gibson, 2008). Most information about the 
effects of prebiotics on the immune system comes from experimental trials with inulin and 
FOS. The general observations are that inulin consumption increases the phagocytic 
capacity of macrophages and the production of secretory immunoglobulin A (IgA-s), which 
plays an important role in the defense of the gastrointestinal tract (reviewed in Van Loo, 
2004). However, the enhancement of the specific response of delayed type hypersensitivity 
in an influenza vaccination model used as a marker for Th1 type immunity has been shown, 
in rats supplemented with a mixture of GOS/FOS (ratio 9:1; optimum at 5% w/w of total 
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diet) as well as the increase of the proportion of fecal bifidobacteria and lactobacilli 
(maximal effect at 10% w/w of total diet), whereas FOS/inulin (2% w/w of total diet) 
enhanced the specific response of delayed type hypersensitivity but did not affect the 
proportion of fecal bifidobacteria and lactobacilli (Vos et al., 2006).  
Mice which consumed a diet rich in oligofructose and inulin showed greater activity 
in the Natural Killer (NK) splenic cells and increase in phagocytic activity of peritoneal 
macrophages. Furthermore, a decrease in total IgA in the feces was observed, when 
considering the total volume of feces produced (Kelly-Quagliana et al., 2003, Kudoh et al., 
1999). Severe colitis was also experimentally controlled in a genetically susceptible host 
fed with a mixture of lactobacilli, bifidobacteria, and inulin (Schultz et al., 2004).  
The addition of mannanoligosaccharides to the diet of turkey poults reduced the pro-
inflammatory immune response induced by LPS (Ferket, 2002), as well as increased the 
humoral immune response in the vaccination of poultry against Infectious Bursal Disease 
Virus (IBDV) and Newcastle Disease Virus (NDV) (Oliveira, Figueiredo-Lima, Faria 
Filho, Marques, & Moraes, 2009). However, the FOS and MOS intake (5 g/kg in addition 
to basal diet) resulted in a significant reduction in the proportion of B cells and in mitogen 
responsiveness of lymphocytes in cecal tonsil of chickens in comparison with those 
observed in birds treated with the antibiotic zinc bacitracin (Janardhana et al., 2009).  
Although well designed clinical trials in humans are scarce, the specific effects of 
prebiotics have been investigated, particularly in inflammatory disorders in infants and 
elders. Some of the data obtained in these researches are summarized in Table 1. For 
example, Guigoz, Rochat, Perruisseau-Carrier, Rochat, and Schiffrin (2002), while 
studying the effects of supplementing with FOS (8 g/day) in elderly subjects, observed a 
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decrease in the expression and secretion of IL-6 by peripheral blood mononuclear cells. 
Another independent study showed that supplementation of diet of elders with GOS (5.5 g/ 
day) resulted in significant reduction in the production of proinflammatory cytokine IL-6, 
IL-1β, and TNF-α, as well as in increase of the activity of NK cells and production of IL-
10, an anti-inflammatory cytokine (Vulevic et al., 2008).  
In children and teenagers infected by HIV, ingestion of a supplement containing FOS 
(3,75 g/day) for three months resulted in an increase in lymphocyte proliferation specific to 
the BCG (Bacillus Calmette-Guérin) vaccine that was used to evaluate cellular immune 
response in these patients (Moreno, 2007). A diet enriched with a FOS:inulin mix (5%) was 
able to trigger and stimulate the gut mucosal immune system and supports the concept of 
using food supplements containing a FOS:inulin mix to enhance the oral vaccine efficacy. 
This study reflected the capacity of FOS mix to promote a Th1-like adjuvant effect which 
might have supported the strong specific humoral responses observed in FOS mix-fed mice. 
Any signs of immune suppression or other potential side effects in the study upon feeding 
with FOS mix were not discerned. The results showed that there was an improvement in the 
Salmonella vaccine protection rate upon feeding with the FOS mix (from 40 to 73%) 
(Benyacoub et al., 2008). In infants who lack the transfer of protective maternal SIgA from 
breast milk receiving standard formula containing a mixture of 0.6 g GOS+FOS (9:1)/100 
mL until the eighth month, a tendency for increase in endogenous secretory IgA in the feces 
was observed (Bakker-Zierikzee et al., 2006).  
Oligosaccharides were also able to alter the development of the postnatal immune 
system in a prospective clinical double-blind randomized trial controlled by placebo, 
conducted with 259 infants at risk for atopy. In the infants who ingested a mixture with 0.8 
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GOS+FOS (9:1)/100 mL, during the first six months of life, the cumulative incidence of 
atopic dermatitis was significantly reduced (Moro et al., 2006).  
Some investigations have pointed out that the use of prebiotics, or other microbiota 
modulators, could contribute to the prevention of allergic diseases in human population. 
The normal intestinal microbiota associated with the gut intestinal mucosa represents the 
first line of defense against various potential pathogens. The recognition and presentation 
of the antigen in the GALT are fundamental for the construction of an immune response, 
whether to develop protection, tolerance, or disease (Canani, Passariello, Buccigrossi, 
Terrin, & Guarino, 2008; Chierici, Fanaro, Saccomandi, & Vigi, 2003; Gibson, 1999). The 
intestinal tract of the newborn is a sterile environment, which becomes colonized by 
microorganisms through breastfeeding. The absence or poor colonization of the intestinal 
mucosa is usually associated with the development of allergic conditions in childhood. The 
oligosaccharides and bifidogenic nucleotides in human milk interact with the sterile 
gastrointestinal tract of neonates, promoting the predominance of bifidobacterias (Ly, 
Litonjua, Gold, & Celedón, 2011; Macfarlane et al., 2007). The adequate colonization of 
intestines is necessary for the development of the immune system, especially in the 
synthesis and secretion of polymeric IgA, as well as balanced production of T helper cell 
response, and modulation of hypersensitivity reactions (Fanaro & Vigi, 2008). In this 
regard, it has been shown that allergic infants display an abnormal “adult-type” 
bifidobacterium flora, with high levels of Bifidobacterium adolescentis strain instead of the 
typical infant flora dominated by Bifidobacterium bifidum (He, Ouwehand, Isolauri et al., 
2001).  
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It was recently demonstrated that the long-term consumption of orally administered 
lactulose (1 or 3%) had an immunomodulatory effect on the composition of T-cell subsets 
in gut-associated lymphoid tissue, secondary lymphoid tissues, and peripheral blood of 
probiotic fed calves, that could impact on calf health (Fleige, Preisinger, Meyer & Pfaffl, 
2009).  
Use of Lactobacillus helveticus M92 in combination with inulin, lactulose, or 
raffinose (10 g/l) resulted in immunomodulation, since the application of these synbiotic 
was able to stimulate the mucosa and the total humoral immune response in mice. The 
combination with inulin showed the best synbiotic effect over both the intestinal microbiota 
and the immune system. The concentration of both secretory IgA and total seric IgA in 
immunized mice was bigger than in the controls (Frece et al., 2009). 
On the other hand, oral treatment with lactulose (10 g/day) during 4months had no 
beneficial effects in patients with intestinal bowel diseases such as ulcerative colitis (UC) 
and Crohn's disease, in particular with regard to clinical activity, endoscopic score or 
immuno histochemical parameters. According to the German version of the Inflammatory 
Bowel Disease Questionnaire (IBDQ), however, significant improvement of quality of life 
was observed in UC patients receiving lactulose compared to the control group (Hafer et 
al., 2007). 
In another prospective, randomized, double-blind, placebo-controlled trial, healthy 
term infants with a parental history of atopy were fed either a prebiotic-supplemented (8 
g/L short-chain GOS/large chain FOS) or placebo-supplemented (8 g/L maltodextrin) 
hypoallergenic formula during the first 6 months of life. The scGOS/lcFOSmixture led to 
significant reduction in the cumulative incidence of allergic manifestations (atopic 
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dermatitis, recurrent wheezing episodes, and allergic urticaria) and in the number of 
infectious episodes (overall, upper respiratory tract infection, fever episodes, and infections 
requiring antibiotic therapy) during the 18 months after the termination of oligosaccharide 
supplementation (Arslanoglu et al., 2008).  
Probiotics and prebiotics may have both adjuvant properties on immune defense, via 
up-regulating Th1 responses, and anti-inflammatory actions which prevent contact 
hypersensitivity responses, via downregulating Th1 responses. In this regard, an 
experimental study showed the dietary supplementation with FOS (50 g/kg diet) and B. 
pseudolongum was partially responsible for the reduction in the 2.4-dinitrofluorobenzene 
(DNFB) induced contact hypersensitivity response by the modulation of antigen-induced 
cytokine production. This effect was associated with an increased production of IL-10 and 
decreased production of interferon-γ, which might be mediated, at least in part, by 
increased proliferation of B. pseudolongum in the gastrointestinal tract. Although 
modulation of antigen-induced production of inflammatory and regulatory cytokines might 
be involved in the inhibitory effect of gut microbiota on contact hypersensitivity response, 
further studies remain to be performed, especially regarding IL-17 production (Sasajima et 
al., 2010).  
A dietary intervention with a mix of prebiotics (scGOS/lcFOS/pAOS; 9:1:1) in mice 
orally sensitized with whey act as a protective effect on allergic symptoms. The prebiotic 
diet caused only a minor reduction in whey-specific Ig. However, partial ex vivo CD25+ 
Treg cell depletion abrogated the protective effects of the adoptive transfer with donor cells 
of whey-sensitized mice fed the prebiotic diet. The results suggest, at least in part, the 
involvement of whey-specific Treg cells in the transfer of tolerance (Schouten et al., 2010).  
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The effect of daily intake of a synbiotic on immune functions of colon cancer patients 
was investigated in a randomized double-blind, placebo-controlled trial with of colon 
cancer and polypectomised patients. No negative effects were observed in cancer and polyp 
patients with daily consumption of the synbiotic (SYN) encapsulated bacteria (1x1010 
colony forming units of Lactobacillus rhamnosus and 1x1010 colony forming units of 
Bifidobacterium lactis) and a 10 g sachet of inulin enriched with oligofructose, for 12 
weeks. The synbiotic supplement had only minor effects on the immune systems of the 
subjects in both groups. It is possible that SYN supplementation in humans preferentially 
affects the gut-associated lymphoid tissues rather than the systemic immune system (Roller, 
Clune, Collins, Rechkemmer, &Watzl, 2007).  
Another set of data suggest beneficial effects of the prebiotic dietary inulin in colon 
cancer prevention. This effect seems to be related to the ability of short-chain fatty acids 
and secondary bile acid deoxycholic acid (DCA), derived from the culture of fecal inocula 
and mixture of inulin enriched with oligofructose, to inhibit growth and induce apoptosis in 
colon cancer cells. However, further studies are necessary to determine whether this 
mechanism could be involved with protection against colon cancer (Munjal, Glei, Pool-
Zobel, & Scharlau, 2009).  
It has been demonstrated that prebiotics such as inulin (5%) may increase Zn 
absorption, a mineral known to play a central role in the immune system since Zn-deficient 
states are characterized by suppressed immune function. Inulin also helped to conserve 
femur Zn concentrations during diet restriction, when dietary Zn was available despite 
reduced energy intake, but not during Zn deficiency when the availability of Zn was 
severely limited (Ryz, Meddings, & Taylor, 2009). 
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4. Conclusions 
Several investigations have suggested that prebiotics can improve health and prevent 
chronic diseases such as obesity, atherosclerosis, hypertension, osteoporosis, diabetes, and 
cancer. Many bacteria residing in the gastrointestinal tract can be stimulated by the 
consumption of prebiotics, but most investigations show that the growth of bifidobacteria 
and, to a lesser extent, lactobacilli, is particularly favored. Although data from human 
studies is still scarce, the results from recent animal studies clearly suggest that prebiotics 
benefit the gastrointestinal tract by stimulating the immune system. The metabolites from 
bifidobacteria and lactic acid bacteria seem to cause positive regulation of the immune 
system, and thus reducing the incidence and severity of inflammatory diseases and allergies 
through the modulation of the functions of resident cells, particularly in the down 
regulation of the production of pro-inflammatory cytokines in those areas.  
Nutritional intervention with prebiotics is an attractive option for modulating both the 
gastrointestinal tract and the immune system, particularly for some divisions of the 
population such as infants, elders, and the immunosuppressed. However, well designed 
clinical studies in humans are still necessary in order to investigate the optimal dosage, 
duration of treatment, and the specific effects of each prebiotic in different dietary matrices, 
in different populations showing different composition of the intestinal microbiota and 
immune response. 
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Legends: 
Figure 1.- The structural formulas of prebiotics. 
Figure 2.- Interactions of prebiotics, probiotics and immune system in the intestinal 
mucosa. Prebiotics promote the growth of healthy microorganisms in intestinal 
environment, which display immunomodulatory functions, and inhibit the adherence and 
invasion of pathogens in the colonic epithelia. 
Table 1.- Trial of prebiotics in inflammatory disorders in human subjects. 
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Abstract 
According to the Pan-American Health Organization (PAHO), there is a growing 
increase of degenerative diseases in countries of the Americas, bringing on disability and 
death of the population. As eating properly is the most effective way to reduce the risk of 
diseases, food scientists are seeking alternatives for more nutritional foods, mainly through 
the investigation of functional compounds in natural foods. Among the functional 
compounds, fructans stand out for their beneficial effects on the animal body, favoring the 
growth of bifidobacteria in the colon that improve gastrointestinal metabolism, as well as 
regulating the levels of serum cholesterol and the absorption of minerals. Besides, fructans 
seem to be involved in the positive modulation of the immune system, mainly in an 
increased resistance to infections and microbicidal activity as well as by the reduction of 
allergic reactions and cancer in experimental models. This paper aims to analyze literature 
data concerning the benefits of consuming the fructans contained in natural food, especially 
their immunomodulatory actions in both animals and humans. 
Keywords: Functional foods, Prebiotics, Fructans, Immune system. 
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1. Introduction 
In most countries throughout the Americas, chronic diseases have presented a greater 
increase in comparison to transmissible diseases, which brings on concern to both public 
and private health care entities. According to the Pan-American Health Organization 
(PAHO) (Organización Panamericana de la Salud (OPS), 2007), the death rate caused by 
chronic diseases will increase 17% in the next 10 years, especially the ones derived from 
diabetes, the incidence of which will increase around 80%. A significant increase in the 
number of overweight men and women in the Americas is expected up to 2015, mainly 
owing to bad eating habits. A great many of such obese people are going to catch diabetes.  
In the last few years, the extensive substitution of natural foods by their industrialized 
peers has seriously affected health as well as the quality of life of human populations. Bad 
eating habits and the excessive consumption of fat, mainly saturated fats, excessive use of 
sugar and salt, and the low intake of starch and dietetic fibers have led to a high incidence 
of chronic degenerative diseases, such as cardiovascular diseases, cancer, diabetes, and 
obesity (Organización Panamericana de la Salud (OPS), 2007).  
In the face of such issues, public health care policies should prioritize action towards 
changing people’s habits, particularly as far as food quality, physical activity maintenance, 
and tobacco-use reduction are concerned. It is estimated that changes in eating habits alone 
should reduce the incidence of cancer at about 30–40% (Organización Panamericana de la 
Salud (OPS), 1997).  
In that regard, an increasing worldwide interest has been developed towards 
functional food, i.e., food with compounds that provide physiological or metabolic activity 
 44 
 
benefits and strengthen the immune system, acting in the prevention and decrease of 
degenerative disorders (Watzl, Girrbach, & Roller, 2005).  
Functional or nutraceutical foods can be found either in their natural or processed 
forms. The natural functional foods are the ones that preserve their innate functional 
nutrients and compounds. The processed foods, on their hand, are the ones to which 
functional ingredients have been aggregated in order to enhance their value (Roberfroid, 
2005).  
Fructans set an example of functional ingredients: also known as non-conventional 
sugars due to their prebiotic properties, fructans make up a good opportunity to add value to 
the product either in terms of functionality or in profitability for the food industry.  
The regular intake of prebiotics such as fructooligosaccharides (FOS) and inulin 
improve a few physiological features, enhancing resistance against intestinal as well as 
extra-intestinal pathogens and promoting good immune response development, including 
the decrease of allergies (Fujitani et al., 2007; Vos et al., 2007).  
The immune system is able to discriminate ‘‘self” molecules from ‘‘non-self” ones 
and to perceive the absence of the ‘‘self” element (Doan, Melvold, Viselli, & Waltenbaugh, 
2008). The main activities of this system are the elimination of pathogens and the 
immunesurveillance against tumors. Such activities are developed by different, though 
integrated elements, which are known as innate and adaptive immune systems. The innate 
immunity comprises an ancestor set of defense mechanisms found in multicellular 
organisms whereas the adaptive immunity is evolutionarily more recent, having appeared in 
the vertebrate group (Abbas & Lichtman, 2005; Doan et al., 2008). Several scientific 
reports have shown an increase in immune system efficiency through the consumption of 
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functional foods, mainly fructans. On an experimental basis, it has been demonstrated that 
the regular intake of such compounds provides resistance against intracellular pathogens 
and lead to a decrease in digestive tract allergies. These effects seem to be correlated to the 
increase in bifidobacteria in the intestinal microbiota through fructan intake (Kelly-
Quagliana, Nelson, & Buddington, 2003; Watzl et al., 2005).  
Due to the large demand for quality eating habits, the inclusion of prebiotics of the 
fructan type in the production of different foods for human use will represent a great 
opportunity to innovate and add value to the functional food industry. This paper is aimed 
at examining the knowledge acquired about the features of fructans as well as at the effects 
from the regular intake of such prebiotics upon the immune system activities in both 
humans and animals.  
 
2. Fructan composition  
Fructans are reserve carbohydrates comprising 01–70 units of fructose, linked or not 
to a terminal sucrose molecule. Fructans can present a linear or branched structure with 
molecules bound together through β(2→6) fructosyl-fructose linkages found in fructans of 
the levan type or β(2→1) bonds found in fructans of the inulin type (Carabin & Flamm, 
1999; Roberfroid, Gibson, & Delzenne, 1993). Fructans of the inulin type are divided in 
two compound groups: inulin and its hydrolysis products (oligofructose) plus the FOS 
(fructooligosaccharides), which are sucrosesynthesized. These carbohydrates have 
generally been differentiated by their polymerization level, which, in inulin, may vary from 
2 to 70 monosaccharidic units with an average value around 10. The FOSs are used to 
describe fructans with a polymerization level lower than 10 (Carabin & Flamm, 1999). The 
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FOS present 1 or 4 fructose molecules connected in the β-(2→1) sucrose position in Fig. 1. 
Their main types are: kestose (GF2), nystose (GF3) and 1- fructofuranosyl nystose (GF4) 
(Passos & Park, 2003; Sangeetha, Ramesh, & Prapulla, 2005).  
The FOSs are non-digestible oligosaccharides (NDOs) considered as non-caloric 
agents as they are resistant against the hydrolytic action of saliva and small intestine 
enzymes. As they reach the colon, the FOS are degraded by intestinal bacteria as 
bifidobacteria, which produce short-chain fatty acids (SCFAs), such as acetate, propionate, 
and butyrate, besides lactic acid, hydrogen and carbon dioxide (Luo & et al., 1996; 
Roberfroid et al., 1993).  
Fructans are reserve carbohydrates found in about 36 thousand vegetable species. In 
the dicotyledon class, the fructans are found in almost every species of the Asteraceae 
family, several of which presenting economic relevance, such as the wild chicory 
(Cichorium intybus) and Jerusalem artichoke (Helianthus tuberosus) (Carabin & Flamm, 
1999; De Carvalho & Figueiredo-Ribeiro, 2001). The fructooligosaccharides can also be 
found as natural compounds in asparagus, beetroot, garlic, chicory, onion, wheat, honey, 
banana, barley, tomato, and rye (Grajek, Olejnik, & Sip, 2005). 
 
3. The immune system 
The immune system of higher vertebrates comprises both innate and adaptive defense 
mechanisms capable of either preventing or limiting infections, in addition to eliminating 
tumor cells. The innate immunity comprehends an ancestor set of defense mechanisms that 
is found in most multicellular organisms, whereas the adaptive immunity is evolutionarily 
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more recent, having appeared in the vertebrate group. The cells involved in the innate 
immunity, such as macrophages, neutrophiles, and dendritic cells present receptors for the 
recognition of molecular patterns in microorganisms, the so-called Pathogen-Associated 
Molecular Patterns (PAMPs), through which they interact with the microbes and phagocyte 
them. Next, the cells destroy these microbes through the action of proteolytic enzymes and 
oxygen free radicals generated in the inner part of the phagolysosomes (Janeway & 
Medzhitov, 2002; Reis & Sousa, 2004). The cells known as Natural Killers (NK) also play 
an important role in innate immunity by eliminating cells that have been altered by virus 
infection or malignant transformation. Several other factors contribute to the efficiency in 
the destruction of exogenous cells within innate immunity, with an impressive role played 
by the Complement System and the inflammatory process, which are responsible for the 
activation and recruitment of phagocytes towards the site where injury or infection is to be 
found (Abbas & Lichtman, 2005).  
In addition to the huge efficiency of phagocytes to eliminate pathogens and 
exogenous substances from the organism, the internalization and antigenic processing 
followed by the exposition of peptidic fragments of antigens processed in its surface lead to 
the activation of adaptive immunity mechanisms. The phagocytes are called Antigen-
Presenting Cells (APCs) as they accomplish this type of activity (Reis & Sousa, 2004).  
The adaptive immunity is based upon lymphocyte activity, cells specialized in the 
recognition of molecular details of exogenous antigens through highly specific antigen 
receptors clonally distributed in its surface. The lymphocytes encompass two main cell 
types: lymphocytes B and T, which are developed in the bone marrow and thymus, 
respectively. Each T lymphocyte owns a single antigen receptor called TCR, composed of 
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two different polypeptidic chains (alpha and beta chains or gamma and delta chains) 
immersed in the cell surface through a carboxy-terminal hydrophobic region. In addition, 
the CD3 molecule is still to be found in association with the TCR, forming the antigen 
recognition complex. This molecule is indistinctly expressed in all T lymphocytes and acts 
in the transduction of cell activation signals triggered as the TCR and the specific antigen 
meet. The T lymphocytes only recognize the antigens that were processed and expressed as 
antigenic peptides associated with the molecules from the major histocompatibility 
complex (MHC) expressed in the surface of the APCs. The T lymphocytes are subdivided 
into two populations with different functional activities, i.e., TCD4+ and TCD8+ 
lymphocytes. The TCD4+ lymphocytes present a helper function (Th) in immune responses 
and interact with the APCs through the class II MHC molecules. The Th lymphocytes may 
be of the Th1 or Th2 types, each one producing, after activation, a given pattern of 
cytokines with diverse immunity functions. CD4+ T cells can leave the thymus already 
expressing the CD25 molecule; in this circumstance act as natural regulators of the immune 
response, and are called T reg cells. In the presence of IL-23, CD4+ T cells can 
differentiate into cells secreting IL-17, and then called Th17, which contributes to the 
pathogenesis of diseases such as asthma, rheumatoid arthritis, lupus and others (Winn, 
2005). The TCD8+ lymphocytes interact with the APCs via antigenic peptides linked to the 
class I MHC molecules, turning into cytotoxic lymphocytes (CTLs), which are able to 
eliminate either infected or malignantly transformed target cells (Abbas & Lichtman, 
2005). 
The B lymphocytes, on their hand, present an antigen receptor called BCR in their 
surface. This receptor is composed of IgM and IgD-class immunoglobulins, which are able 
to establish a direct connection with a given portion of the antigen’s native molecule, which 
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is called epitope or antigenic determinant. A few B lymphocytes can be directly activated 
through the antigen and be differentiated in antibody-releasing plasmocytes. In this case, 
the plasmocytes will always secrete IgM-class antibodies under the same specificity 
presented by the receptor found in the surface of its originating B cell. The antigens that 
activate B lymphocytes directly are called thymus-independent antigens.  
However, most B lymphocytes are connected to the antigen to which they are specific 
and it is internalized by them. The endocytosed antigen is processed in small peptidic 
fragments that will be exposed in the surface of the B lymphocytes in association with the 
class II MHC molecules, becoming an APC for Th lymphocytes. The subsequent 
interaction between Th and B lymphocytes will result in the clonal expansion of both cells 
and in the differentiation of B lymphocytes into plasmocytes. Such plasmocytes may 
secrete immunoglobulins of the same specificity as the original molecule, though in diverse 
classes (IgG, IgA or IgE), depending on the cytokines released by the Th lymphocytes 
involved in their maturation (Janeway & Medzhitov, 2002). 
 
4. Bifidogenic effect of fructans 
According to Hidaka, Eida, Takizawa, Tokunaga, and Tashiro (1986), the benefits 
obtained from the consumption of Fructans for the human organism include the production 
of short-chain fatty acids (SCFAs) the main fuels of colonocytes, that lead to a decrease in 
the intestinal pH, a decrease in the production of putrefactive substances in the intestine, 
and an increase in the bifidobacteria population.  
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The microbiota is a complex ecosystem that shelters around 1014 microbes 
representing between 400 and 500 different species. From the microbiological point of 
view, the digestive tube can be divided into three main regions: stomach, small intestine, 
and colon. As far as the microbial population is concerned, the stomach presents a small 
number of bacteria owing to its low pH; a prevalence of facultative anaerobes is noticed, 
such as lactobacilli, streptococci, and yeast, which are found in the proportion of 100 
colony-forming units (CFU) per mL. The small intestine presents a heavier bacterial load 
composed of facultative anaerobes as lactobacilli, streptococci, and enterobacteria, in 
addition to anaerobes such as Bifidobacterium spp., Bacteroides spp., and Clostridia at 104 
and 108 CFU/mL. Meanwhile, the colon is the region that contains the largest quantity and 
diversity of microorganisms, i.e., around 1010–1012 CFU/mL. The main genders found in 
the colon are Bacteroides, Bifidobacterium, Clostridium, Eubacterium, Bacillus, 
Peptostreptococcus, Fusobacterium, and Ruminococcus.  
The intestinal microbiota plays an important role in human health. The colonic 
microbiota is the predominant target of intestinal ecology in dietetic interventions (Fanaro, 
Chierici, Guerrini, & Vigi, 2003; Rastall, 2004; Shadid et al., 2007). The health-promoting 
effects include: (a) contribution to host’s nutrition; (b) inhibiting the growth of potential 
pathogens; (c) non-digestible fiber fermentation; (d) energy economy; (e) synthesis of B 
and K complex vitamins; (f) metabolism of both plant and drug compounds; (g) production 
of short-chain fatty acids (SCFAs) and polyamines; (h) improvements in motility and 
gastrointestinal function; (i) cholesterol reduction, and (j) stimulation of the local immune 
system (Penders et al., 2006; Sanders & Gibson, 2006; Shadid et al., 2007).  
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A healthy microbiota is the one that is predominantly saccharolytic, with a significant 
prevalence of Bifidobacterium and Lactobacillus, since these genders do not contain known 
pathogens, produce a wide range of antimicrobial agents, and ferment mainly 
carbohydrates, unlike other groups, such as Bacteroides and Clostridia, which ferment 
proteins and amino acids as well (Macfarlane & Macfarlane, 2006; Rastall, 2004).  
The butyric acid, which is the main product resulting from oligosaccharide 
hydrolysis, is the main energetic substrate for the colon mucosa, and seems to play a 
protective role against colon diseases, such as ulcerative colitis and cancer. Both propionic 
and acetic acids produced by these microorganisms seem to beneficially interfere with the 
metabolism of lipids and carbohydrates. The increase in SCFAs can also lead to pH 
decrease, which, on its hand, may stimulate intestinal absorption of minerals in the colon as 
well as increase local blood flow. Furthermore, oligosaccharide digestion products are able 
to suppress the in vitro activity of the nuclear transcription factor kappa B (NFκB), a key 
element for inflammatory responses (Rodríguez-Cabezas et al., 2002). 
 
5. The immunomodulatory effect of fructans 
Fructans (inulin and FOS) reach the large intestinal region where they are, to a greater 
or lesser extent, hydrolyzed and metabolized by the local microbiota, selectively 
stimulating the growth of certain bacterial species that are considered as being beneficial 
for the host. Therefore, the fermentation of such sugars achieve clinical meaning due to 
their important metabolic effects on large intestine physiology, showing the ability to affect 
the metabolism of carbohydrates, fats and minerals, and to act in immunologic function 
modulation (Delzenne, Daubiol, Neyrinck, Lasa, & Taper, 2002; Lobo & Filisetti, 2003; 
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Schley & Field, 2002; Scholz-Ahrens, Schaafsma, Vanden Heuvel, & Schrezenmeir, 2001; 
Scholz-Ahrens & Schrezenmeir, 2002; Wolever, 1995). The following information is about 
the benefits from the intake of prebiotic compounds of the fructan type for the physiology 
of both digestive and immune systems. 
 
5.1. Gastrointestinal diseases 
Evidence shows that the intake of prebiotics of the non-digestible oligosaccharide 
type (NDO) leads to the increment of fecal volume (1.5–2 g per NDO gram ingested), and 
to the normalization in the frequency under which feces are eliminated, thus regularizing 
intestinal functions of constipated individuals (Gibson, Beatty, Wang, & Cummings, 1995 
Apud Van Loo et al., 1999). Research performed with laboratory animals showed that the 
daily oral administration of inulin produced an anti-inflammatory effect over the distal 
colitis pattern induced by Dextran Sodium Sulfate (DSS) in mice. As a result from the 
fermentation of inulin by the colonic microbiota, an increase in the production of short-
chain fatty acids was observed in the colonic lumen as well as a mild acidification of its 
contents. A reduction in the local inflammatory activity and in damages caused by the 
inflammatory agent to the distal colon mucosa was simultaneously observed (Videla et al., 
2001). The current research found out that inulin consumption increased the number of 
bifidobacteria and lactobacilli in the colon. In addition, it reduced the number of 
clostridium and bacteroids as well as other non-specific anaerobic microorganisms and 
aerobic microorganisms. The authors concluded that the increase in the number of 
lactobacilli after the intake of inulin significantly contributed to the anti-inflammatory 
effect ascribed to inulin (Videla et al., 2001).  
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5.2. Mineral absorption 
The stimulation of fructan-induced absorption of minerals such as Ca, Mg, and Fe 
through inulin and transgalactosilated oligosaccharides has been repeatedly confirmed by 
studies performed with mice (Scholz-Ahrens & Schrezenmeir, 2002). It has also been 
noticed that, in humans, the consumption of fructans of the inulin type leads to an increase 
in Ca absorption, resulting in bone mineral density augment (revised by Van Loo et al. 
(1999)). Several studies actually prove that the daily intake of combined fructans in both 
short and long chain inulin types significantly increases calcium absorption, besides bone 
mineralization during the puberty growth period. The effects of these dietetic factors on 
calcium absorption seem to be modulated by genetic factors, including genetic 
polymorphism of the specific vitamin D receptor (Abrams et al., 2005). Moreover, studies 
have shown that the consumption of fructans of the inulin type also exerts impact on 
osteoporosis progression owing to the increase in calcium bioavailability with a meaningful 
increase in bone density and mineral mass (Roberfroid, 2000). 
 
5.3. Neoplasias 
The regular intake of pre- and probiotics also leads to a reduction in azoxymethane 
(AOM)-induced colon carcinogenesis in animal patterns. Although the active mechanisms 
of prebiotics are not very clear for carcinogenesis control, literature suggests that they may 
act through a combination of factors involving the increase in SCFA production, the 
reduction in proliferative cancer cell activity, and the reduction in the expression of certain 
enzymes involved in colon cancer pathogenesis (revised by Femia et al. (2002) and Van 
Loo et al. (1999)). In that regard, it has been noticed that chicory fructans – either of the 
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oligofructose or of the inulin types – cause apoptotic effects in the tumor cells of colon 
cancer induced in mice, thus proving their tumoricidal properties (Hughes & Rowland, 
2001). 
 
5.4. Cholesterol and triglyceride reduction 
Evidences have indicated that moderate level ingestion of inulin or oligofructose 
affect the fat metabolism of experimental animals and humans (Delzenne et al., 2002; Van 
Loo et al., 1999). Hence, it has been demonstrated that oligofructose consumption along 
with fat-rich diets leads to the decrease in mice serum triglycerides owing to the extra-
hepatic increase in the catabolism of triglyceride rich lipoproteins (Kok, Taper, & 
Delzenne, 1998). Likewise, studies performed in animal patterns with hyperlipidaemia 
present meaningful reductions in triacylglycerol and regular decrease in the levels of total 
cholesterol and LDL owing to oligofructose consumption (Williams & Jackson, 2002). The 
reduction in the risk of atherosclerotic cardiovascular disease is directly correlated to 
dyslipidaemia, especially in hypertriglyceridaemia and in insulin resistance, both associated 
with hypercaloric diets, mainly the carbohydrate-rich ones. Also in these cases, the regular 
consumption of fructans has brought on benefits related with either the reduction or 
prevention of cardiovascular disease (Roberfroid, 2000). 
 
5.5. Immune system modulator 
Changes in the composition and metabolic features of gastrointestinal tract bacteria 
resulting from a fructan-rich diet bring about positive effects upon the immune system 
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(Buddington, Donahoo, & Buddington, 2002). Research made with rodents demonstrated 
that diets with plenty of inulin and oligofructose increase the quantity as well as the 
diversity of lactic acid bacteria in the gastrointestinal tract, leading to a general 
improvement in animal health (Buddington et al., 2002). The lactic acid bacteria (LAB) 
stimulate various innate and acquired immune functions possibly through cytokine 
expression modulation (Buddington et al., 2002). Mice undergoing an oligofructose and 
inulin-rich diet presented greater activity of the splenic Natural Killer cells, increase in the 
phagocytic activity of peritoneal macrophages, in addition to a decrease in feces total IgA 
when the total fecal volume produced is taken into account (Kelly-Quagliana et al., 2003; 
Kudoh et al., 1999). It has been experimentally demonstrated that a FOS/inulin-based diet 
results in the rise of the IL-10 and IFN-γ production for cells in the Peyer’s patches, which 
suggests that prebiotic-based supplements simultaneously activate different subpopulations 
of T lymphocytes and/or dendritic cells of the gastrointestinal tract (Watzl et al., 2005). 
Further studies demonstrated that mice undergoing a fructan-based diet (FOS/inulin) 
presented a reduction in colon cancer (Femia et al., 2002) as well as a reversion in the 
inhibition of NK cell activities provoked by the administration of the AOM carcinogen 
(Roller, Rechkemmer, & Watzl, 2004). Furthermore, mice fed with a diet containing 
fructans presented an increased resistance against infections caused by Salmonella and 
Listeria and against tumor development, which is consistent with the increase in NK cell 
functions and macrophages found in those animals (Buddington et al., 2002). 
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6. Conclusions 
The general health condition of humans depends both on hereditary factors and 
environmental interferences in the organism, including life style and access to appropriate 
eating habits. The so-called functional foods have gradually become more popular due to 
the benefits that seem to be related to the consumption of such foods. Although functional 
foods do not constitute a panacea capable of healing diseases and other conditions that 
affect human beings, experimental evidences have been showing that their compounds have 
prebiotic properties, i.e., the ones that act in favor of the gastrointestinal tract functions. 
Among the most important compounds found in functional foods are the oligosaccharides 
of the fructan type acting as bifidogenic agents and immune system stimulators associated 
with the intestinal mucosa. Literature presents evidences pointing to the fact that the 
formation of a microbiota rich in bifidobacteria and lactic acid bacteria may regularize fat 
metabolism through triglyceride synthesis and mineral absorption, and such effects are 
positively correlated with the reduction of colon cancer incidence. The metabolites 
produced by bifidobacteria and lactic acid bacteria also play an important role in immune 
system regularization. There has been experimental evidence of their participation in the 
control of inflammatory diseases and allergic intestinal reactions through the modulation of 
resident cell functions, particularly in the downregulation of the pro-inflammatory cytokine 
production in these places. Although experimental results clearly suggest that fructans play 
a prominent role for the improvement in the functions of the digestive tract and immune 
system associated with the mucosae, the studies about the effect of fructans in daily diets 
for human beings are scarce and additional research is required to establish them more 
clearly. 
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Legends: 
Figure 1.- Structural formulas of fructans 
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Abstract 
Among the natural functional foods appears yacon (Smallanthus sonchifolia), an 
Andean tuberous root, which contains nutraceutical compounds of fructooligosaccharides 
(FOS) type, inulin and phenolic compounds. Consumption of FOS and inulin favors the 
growth of bifidobacteria in the colon, helping the gastrointestinal metabolism and 
regulating the serum cholesterol and mineral absorption. Besides, prebiotics promotes a 
positive modulation of the immune system, mainly translated into increment of resistance 
to infections, of microbicidal capacity and decrease of allergic reactions. Some studies 
show the potential of yacon as alternative food source for the necessary changes in the diet 
of our population. This article intends to describe the functional potential of yacon, aiming 
at encouraging its cultivation and industrial processing for the benefit of population health. 
Keywords: Prebiotics, Fructans, Fructooligossacharides, Phenolic Compounds. 
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1. Introduction 
In recent years, extensive replacement of natural food by industrialized food has 
caused great impact on the health and quality of life of human population. Poor diet and 
bad eating habits have produced a high incidence of degenerative chronical diseases like 
cardiovascular problems, obesity, cancers and diabetes (ORGANIZACIÓN 
PANAMERICANA DE LA SALUD (OPS), 2007).  
Before this problem, public policies in health must prioritize actions that lead to 
changes in habits of their populations, particularly in relation to the quality of food, 
maintenance of physical activity and reduction of tobacco use. It is estimated that only 
changes in eating habits would reduce cancer incidence by about 30-40% 
(ORGANIZACIÓN PANAMERICANA DE LA SALUD (OPS), 1997).  
There is a worldwide increasing interest in nutraceutical foods, i.e., foods with 
properties that benefit physiological and metabolic activities, acting in the prevention and 
reduction of degenerative diseases (WATZL et al., 2005). 
Consumption of prebiotics such as FOS and inulin enhaces some physiological 
functions, promotes the immune response and increases the resistance to pathogens (VOS 
et al., 2007). 
Yacon is an Andean plant that is attracting global attention for its prebiotics 
advantages and benefits, due to its high content of non-digestible oligosaccharides (NDOs) 
such as fructooligosaccharides and inulin, as well as phenolic compounds (GRAEFE et al., 
2004; VALENTOVÁ et al., 2006) (Fig. 1).  
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The tuberous roots of yacon contain large amounts of inulin and 
fructooligosaccharides - even more than chicory and artichokes - and are used as natural 
sweeteners and syrups for digestive problems, particularly to balancing the intestinal 
microbiota. Traditional population attributes antidiabetic properties to yacon dry leaves, 
used in the preparation of teas used in low calorie diets.  
In addition to prebiotics, yacon has a reasonable amount of phenolic compounds such 
as flavonoids, phenolic acids and tryptophan, which shows various defense functions of 
antioxidant, anti-inflammatory, antimicrobial and anticancer type. The phenolic compounds 
in yacon preserve biomolecules, such as DNA and lipids and proteins of cell membranes, 
against damage caused by free radicals (SIMONOVSKA et al., 2003). 
Several studies show an increase in the efficiency of the immune system by the intake 
of nutraceuticals, especially fructans. Experimentally, it has been shown that regular 
consumption of these compounds confers resistance to infection by intracellular pathogens 
and leads to a reduction in allergies in the digestive tract. It seems to be correlated with the 
rise of bifidobacteria in the intestinal microbiota by the consumption of fructans (WATZL 
et al., 2005). 
The absence of toxicity associated with beneficial metabolic activity are important 
aspects to consider when choosing the basic raw material for processing products 
containing sugar to be used in treating obesity and other aspects of diabetes 
(VALENTOVÁ et al, 2006). Since it has such properties, yacon has great potential to 
become a profitable niche market in systems of small-scale farming in Brazil, especially in 
São Paulo state, emphasizing the practice of organic cultivation (GRAEFE et al., 2004). In 
producer countries, there is a wide variety of products made of yacon such as flour, 
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dehydrated products, slices type "chips", tea (dried leaves), juices, purees, sweeteners in the 
form of syrup with high content of FOS (NATIONAL RESEARCH COUNCIL (NRC), 
1989). 
Due to the high demand for quality food, the inclusion of yacon as a source of 
prebiotic of fructan type in the production of different foods for human use represents a 
great opportunity for innovation and for adding value in the functional food industry. In this 
article, we intend to examine the current knowledge on the functional characteristics and 
the effects of regular consumption of yacon on human and animal physiology.  
 
2.    Yacon root 
Yacon is plant from the Andes in South America, which is widespread from 
Venezuela to northwestern Argentina (ZARDINI, 1991). Yacon is cultivated between 900-
3500m above sea level in Peru, between 600-2500m in Bolivia and Ecuador, and between 
600-800m in Argentina (NATIONAL RESEARCH COUNCIL (NRC), 1989). 
Yacon has been part of the diet of Andean people since pre-Columbian times. In the 
last decade of the 20th century, the cultivation of yacon has spread to several countries 
outside the Andean region, such as western New Zealand, Europe, USA and Japan, due to 
the medicinal properties of its roots and leaves (NATIONAL RESEARCH COUNCIL 
(NRC), 1989) (GRAU & REA, 1997). The Czech Republic has been a pioneer in the 
cultivation of yacon in Europe (VALENTOVÁ et al., 2005). In Brazil, yacon is becoming 
an important crop, especially in São Paulo.  
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According to Zardini (1991), the name yacon derives from the Quechua plant "yaku", 
which means water. But it is also known in other regions by other names such as (1) 
Arboloco, (2) Aricoma, (3) Jícama/chícama, (4) Yíquima, (5) Jiquimilla, (6) Llacon. In 
English, it is known as “yacon strawberry”, and in French is “poire de terre”. 
Yacon was initially classified as Polymnia (Compositae, Heliantheae), but further 
studies ranked the species that grow in Central and South America in the genus 
Smallanthus (NATIONAL RESEARCH COUNCIL (NRC), 1989). The yacon employed in 
the diet of the indigenous tribes that inhabit the high mountains of the Andean region 
belongs to the species Smallanthus sonchifolius, of the family Asteraceae (GRAU & REA, 
1997).  
Yacon is sold in markets and fairs in the Andean region with apples, chirimoyas, 
avocados and pineapples and not along with tubers or roots (NATIONAL RESEARCH 
COUNCIL (NRC), 1989). In Peru, Bolivia, Ecuador or Argentina, it is usually eaten at 
religious festivals, such as Corpus Christi and All Souls' Day. Yacon is usually consumed 
peeled and fresh, like a fruit, and in fruit salad with bananas, oranges and papayas. It can 
also be baked in the oven or be consumed in the form of refreshing beverage by extracting 
its juice.  
In the early 1990s, a Brazilian farmer born in Japan introduced this specie in the State 
of São Paulo. In the region of Capão Bonito/SP, the tubers of 60-80g are planted in beds of 
1.0m wide by 0.4m high, spaced 1.4m between rows and 0.9m between plants (VILHENA, 
1997). 
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The leaves of yacon have several soluble phenolic compounds in water that enable an 
epiphytic bacterial flora with very particular metabolic properties, inhibiting the attack of 
pathogens (VALENTOVÁ et al., 2005).  
The roots of yacon can weigh between 200-500 grams each, and can reach up to 
2000g. Each plant produces bunches of 5-20 units, giving an average of 5 kg/plant. The 
freshly harvested roots are insipid, but after about 3-5 days of exposure to the sun, they 
become juicy and sweet. The taste of sweet yacon has been described as similar to a fresh 
apple or watermelon (NATIONAL RESEARCH COUNCIL (NRC), 1989) (Fig. 2). 
As to its chemical composition, the fresh roots of Yacon have 69-83% of moisture, 
0.4 to 2.2% of protein and 20% of sugars (NATIONAL RESEARCH COUNCIL (NRC), 
1989). The tuberous roots contain as a percentage: 3.59 of ash, lipids from 0.3 to 1.5, 3.88 
of crude fiber, nitrogen free extractable of 85.19, K2O 1.76, 0.18 to CaO, 0.13 MgO and 
0.31 P2O5. It is about 35% of fructose and 58% of glucose + sucrose (HOLA & MICHL, 
1996). 
The oligosaccharides from yacon have repeated units of β-1.2-D-frutoranosil with 
terminal sucrose, being, therefore, oligosaccharides of inulin type. The major FOSs in 
yacon are kestose, and 1-nystose frutosilnistose, similar to those found in the tubers of 
Jerusalem artichoke (Helianthus tuberosus) (PASSOS & PARK, 2003). 
Levels of sugars in yacon roots may vary depending on factors such as localization, 
farming, the growing season and harvest time and temperature in the post-harvest. In 
Brazil, it has been found 34-55% of FOS, 7-9% of glucose, 13-14% of fructose and 10-13% 
of sucrose (LOBO et al., 2007; CHOQUE et al., 2012). In Peru, researchers have found 40-
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70% of FOS, 5-15% sucrose, 5-15% fructose and less than 5% glucose (dry basis) 
(PEDRESCHI et al., 2003; MANRIQUE & PARRAGA, 2005).  
Yacon contains low-polymerization β-oligosaccharide, inulin, small amounts of 
vitamins and minerals and contains no starch. The most abundant minerals in yacon are 
calcium and potassium. In addition, the yacon juice is rich in free essential amino acids 
(KAPULER & GURUSIDDIAH, 1994). The tuberous yacon root is rich in bioactive 
substances such as phenolic compounds, ester derivatives, methyl esters, and glycosides. 
These compounds occur naturally in both leaves and roots. 
Polyphenols of Smallanthus sonchifolius produce acrid or astringent flavor of the 
leaves and barks, as well as they affect an odor typical perception. Polyphenols are also 
substrates for the enzymatic browning of damaged tissues, becoming green or black 
substance by a condensation reacting of polyphenol compounds with amino acids and 
enzymatic polymerization of polyphenols. By contrast, the phenolic and flavonoid 
compounds can modulate lipid peroxidation involved in atherogenesis, thrombosis and 
carcinogenesis through antioxidant activity on super-oxide O2 ion (ZHISHEN et al., 1999). 
Yacon juice contains 850ppm of polyphenolic compounds such as chlorogenic acid, 
considered the main antioxidant of yacon along with tryptophan (TAKENAKA et al, 2003). 
The phenolic acids seem to be responsible for the biological activity of yacon, including 
effects anti-hyperglycemic, cito-protective and waste disposal. Total phenol levels in young 
leaves of yacon were lower than in leaves collected at the time of tuber harvest 
(VALENTOVA et al., 2006). 
The yacon is rarely used in cooking because of its short lifetime and their rapid 
browning of juices and injured tissues. Yacon root quickly darkens in storage even at low 
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temperatures. After cutting and during processing, the dimming trend may be related to its 
phenolic content, especially the levels of caffeic and chlorogenic acids and endogenous 
activity of polyphenol oxidase. Although, the presence of polyphenol oxidase from yacon 
has been demonstrated, there are not any published studies on these enzyme properties 
(NEVES & DA SILVA, 2007). 
 
 3.   The functional effects of yacon root  
Yacon administered as dietary supplement is well tolerated and produces no negative 
response, toxicity or adverse nutritional effect. Besides that, its low glucose content and 
high contents of fructooligosaccharides allow the study of the possible effects in patients 
with metabolic diseases, such as diabetes and metabolic syndrome (GENTA et al., 2005). 
In this regard, yacon proved to have an effect in reducing temporal levels of glucose in 
normal and diabetic rats with hyperglycemia (AYBAR et al., 2001; VALENTOVÁ et al., 
2005).  
Because of its inulin and FOS content, it is possible that yacon presents the most 
important prebiotic characteristics, i.e., resistance to digestion in the upper digestive tract, 
being hydrolyzed and fermented only at the end of the path by colon bacteria. Thus, the 
intake of yacon could benefit the development of colonic microbiota by its potential natural 
bifidogenic effect. Recently, it was shown the tendency of certain probiotics, such as 
lactobacillus and bifidobacteria to ferment FOS in yacon roots; that is why this root has 
been considered a new option in prebiotics (PEDRESCHI et al., 2003). Bifidobacteria 
inhibit the growth of putrefactive bacteria in the colon, promote the absorption of Ca2+ and 
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PO43+ ions, and synthesis of B vitamins, besides stimulating the immune system 
(ROBERFROID, 2005).  
Supplementation of diets with yacon flour in experimental diabetes has shown a link 
between FOS consumption and the insulin production, at least in part, via the stimulation of 
insulin release and/or insulin-like activity by FOS (HABIB et al., 2011). It seems that the 
regular intake of yacon flour exerts its lipid-lowering activities through the activation of the 
lipoprotein lipase enzyme and a slight increase in fasting plasma insulin levels (HABIB et 
al., 2011). For these characteristics, the saccharides in yacon, particularly β-(2 → 1) 
fructooligosaccharides could indeed modulate the metabolic syndrome that occurs in type-2 
diabetes and dyslipidemia, risk factors for atherosclerosis. 
It has been shown that polyphenolic compounds may alter glucose metabolism and 
antihyperglycemic activity acting like antidiabetic agents. This effect on glucose 
metabolism may be mediated by the insulin-like effect or by improvement in antioxidant 
status (CHEMLER et al., 2007). In this regard, phenolic extracts of yacon leaves were able 
to reduce glucose production in rat hepatocytes by increasing glucokinase mRNA 
expression (VALENTOVÁ et al., 2004; VALENTOVÁ et al., 2007).  
Among the phenolic compounds present in yacon roots, chlorogenic acid, tryptophan 
and derivatives of caffeine acid predominate. As natural antioxidants, these compounds are 
of great importance to human health, particularly in protecting cell membranes against 
damage from oxygen radicals and its consequences in cardiovascular disease and cancer 
(NEVES & DA SILVA, 2007). Antioxidant activity and cito-protective effect against tert-
butylhydroperoxide in a model of oxidative damage in rats’ hepatocytes were found in 
alcoholic extracts of yacon leaves (SIMONOVSKA et al., 2003). Trials in humans have 
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also reported the antioxidant activity of phenolic compounds present in yacon leaves, acting 
to prevent chronic diseases, such as atherosclerosis, a disease that involves the participation 
of free radicals in its development (VALENTOVÁ et al., 2005).  
A search using diabetic rats showed that the hydro-ethanolic extract of yacon leaves 
significantly reduced serum glucose levels. Furthermore, treatment with the extract restored 
the activity of plasma enzymes and reduced diabetic animals’ body weight gain. According 
to the authors, the inhibitory action of hyperglycemia induced by streptozotocin (STZ) can 
be attributed to the fact that yacon induces to an increase in plasma insulin concentration 
(BARONI et al., 2008). 
Studies with yacon syrup, fructooligosaccharide source revealed that their 
consumption over a long period produced beneficial effects on obese and slightly 
dyslipidemic in pre-menopausal women’s health with insulin resistance. The daily 
consumption of yacon syrup produced a significant reduction in body weight, waist 
circumference and body mass index. It was also observed reduction in fasting serum insulin 
and an index of homeostasis. Furthermore, ingestion of yacon syrup increased the 
frequency of defecation and satiety (GENTA et al., 2009). 
A recent study evaluated the hypoglycemic activity of phenolic compounds in organic 
extracts from yacon leaves in Wistar rats. The results led to conclude that enhydrin, the 
main sesquiterpene lactone from yacon leaves and caffeic acids, chlorogenic acids and 
three dicaffeoilquinic (CAF, 3-CQ; 3.4-DCQ, 3.5 and 4.5-DCQ -DCQ) are related to the 
hypoglycemic effect, since they reduced levels of blood glucose in diabetic animals 
(GENTA et al., 2010). 
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Two new sesquiterpene lactones and eleven known melampolides were isolated from 
yacon leaves and showed nitric oxide inhibition (NO) by LPS in murine macrophages 
(HONG et al., 2008). 
Low pH and production of SCFA due to the consumption of prebiotics result in the 
hypertrophy of the mucosal cells, enlargement of the intestinal surface and enhance 
solubility of mineral ions (ROBERFROID & DELZENNE, 1998). Yacon consumption for 
relatively short period also resulted in increased intestinal absorption of minerals and bone 
mass, favoring the biomechanical properties of bone in rats (LOBO et al., 2007). The 
enlargement of the caecal wall observed after the consumption of yacon seems to contribute 
to the increased mineral absorption in those animals. In fact, several studies show that daily 
consumption of inulin-type fructan combination of short and long chains increases 
significantly calcium absorption and bone mineralization during pubertal growth. Effects of 
these dietary factors on calcium absorption appear to be modulated by genetic factors, 
including genetic polymorphism of specific D-vitamin receptor (ABRAMS et al., 2005). It 
has been observed that consumption of inulin-type fructans also provides a reduction in 
osteoporosis progression by increasing the bioavailability of calcium with a significant 
increase in density and mass mineral bone (ROBERFROID, 2005). 
Studies by Pinto and colleagues (2001) showed that yacon produces antimicrobial 
compounds and pesticides, which could explain the fact that in its cultivation it is hardly 
necessary to use pesticides. These authors reported the inhibition of aflatoxin production 
when aqueous and ethanol yacon extracts are added to Aspergillius flavus cultures (PINTO 
et al., 2001). Recently, Joung and colleagues (2010) showed that n-hexane fraction of 
yacon leaf extract have antimicrobial activity against six different strains of methicillin-
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resistant Staphylococcus aureus (MRSA) in the presence of 4000 lux, with a minimal 
inhibitory concentrations (MICs) assay (15.6 g/ml). No activity was detected when the tests 
were performed in the absence of light. 
 
4. Yacon root processing 
There is great potential for commercial products that are generated from yacon. In 
this sense, the National Research Council ranked it as promising raw material based on its 
high content of fructans (ZARDINI, 1991). Due to its high concentration of fructose, yacon 
root is a fruitful source for development of natural sweeteners and syrups for people with 
digestive problems. Yacon leaves are consumed in teas for diabetic patients or those who 
suffer from digestive and kidney diseases. 
Some studies have shown that incorporating inulin and fructans in various foods, 
especially baked goods, makes them acceptable to consumers because of their sensory 
characteristics. Yacon syrup has already been incorporated into delicious product 
formulations, considered "light” easy to chew and with porous texture. Likewise, products 
using inulin, low calorie, are known for their sensory characteristics such as neutral and 
mild flavor that increases palatability, stability and acceptability (MOSCATTO et al., 
2006). 
There are already some industrial products derived from yacon on market, such as: 
flour, candy, sliced-chip, teas, nutritional drinks and purees. Hisa and colleagues (1996) 
patented a method for preparing nutritional drinks from skim milk and yacon juice 
fermented by the action of lactic acid bacteria (Lactobacillus plantarum). According to the 
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authors, the method helps to counteract the astringent characteristic of yacon, and prevent 
from FOS degradation. In the 90s, drinks were developed in Japan from milled yacon 
subjected to the action of cellulase at 45°C for 2 hours. The juice was used as a sweetener 
in formulations ready to drink (KANEGAFUCHI et al, 1994). "Chancaca" is a concentrated 
sweet with high content of sugars that Andean natives prepared by boiling the root juice 
until crystallization and resulting in solid blocks of dark brown color (NATIONAL 
RESEARCH COUNCIL (NRC), 1989). Fructose from yacon has a sweetener power of 30-
70% greater than sucrose, besides being a non-caloric sweetener. Finally, the presence of 
inulin in the yacon tubers is of great interest to inulinase's industrialization produced by 
microorganisms (CAZETTA et al., 2005). 
 
5. Conclusions 
According to OPS, the health status in humans depends on both hereditary and 
environmental factors, including lifestyle and access to adequate food. In this respect, the 
functional foods are gaining more supporters because the benefits are associated with their 
consumption. Yacon, a natural resource from Andes, has great potential as functional food 
for its high content of fructooligosaccharides and inulin that promote a good intestinal 
development in the colonic microbiota. In addition to the roots, yacon’s leaves are also 
exploited because their phenolic compounds, to which has been attributed antioxidant 
properties that protect cell membranes against damage caused by oxygen radicals and its 
consequences in cardiovascular disease and cancer. Its regular use may benefit patients 
with digestive and kidney diseases, as well as those with diabetes and metabolic syndrome. 
The high levels of FOS and phenolic compounds represent a potentially profitable niche for 
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the yacon in the farming systems at small scale, characterized by ecological practices and 
local processing, thereby contributing to sustainable development of the region. An 
alternative production may be sweet syrups and natural sweetener for people with digestive 
problems and obesity, reaching a wider group of beneficiaries. 
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Legends: 
Figure 1.- Functional effects of yacon plant. 
Figure 2.- Yacon plants.  A) Vegetative and reproductive organs; B) Yacon roots; C) Slices 
of yacon root (Sources: A) http://www.motherearthnews.com/multimedia/image-
gallery.aspx?id=74438&seq=1; B) http://yacon.wordpress.com/about/; C) G.T. Choque-
Delgado). 
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Abstract 
Objective: Due to its high fructooligosaccharides (FOS) and inulin contents, the yacon root 
(Smallanthus sonchifolius) has excelled in traditional Andean medicine, where it is used as 
a substitute for cane sugar in diabetes and for obesity prevention. This study evaluates the 
physiological and immunological effects of incorporating yacon flour (Smallanthus 
sonchifolius) in the normal diet of mice. 
Methods: BALB/c mice were fed an AIN-93M diet supplemented with 5% commercial 
FOS or either 3% or 5% yacon FOS. Thirty days later, weight gain and food intake, serum 
antibody levels of IgA, IgM, IgG, fecal levels of IgA, nitric oxide (NO) production in 
peritoneal macrophages, T and B lymphocytes frequency in peripheral blood, T lymphocyte 
proliferative capacity, and cytokine production were evaluated. 
Results: Mice fed diets supplemented with commercial or yacon FOS showed no 
significant differences in weight gain and nitric oxide and cytokine production by 
peritoneal macrophages in comparison with the control group, except the IL-1β production 
that was more reduced. Similarly, no differences were observed in serum immunoglobulin 
production or T and B-lymphocyte frequency in the peripheral blood and spleen. 
Significant increases were observed in the splenic T lymphocyte proliferation and IFN-γ 
production, as well as in fecal IgA levels in mice fed a diet containing 3 or 5% of yacon 
FOS in comparison with control group.  
Conclusion: These results indicate that intake of yacon FOS do not alter the peripheral 
immune system equilibrium and promotes the production of fecal IgA.  
Keywords: Yacon root; fructooligosaccharides; immunomodulation. 
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1. Introduction 
The absence of a balanced diet containing carbohydrates, proteins, and lipids deprives 
the immune system of components necessary to create and sustain an effective immune 
response [1]. Dietary imbalance is associated with the development of chronic diseases, 
such as cardiovascular disease, type 2 diabetes, and cancer, greatly affecting the quality of 
life. "Immunonutrition" is a field of research that studies the relationship between food 
intake and a functional immune system [1,2,3]. Currently, research in this area is 
concentrated in on evaluating potential immunomodulators resulting from consuming 
functional diets.  
Several studies have shown increased immune system efficiency following the 
consumption of functional foods such as fructans, which are non-digestible 
oligosaccharides [4,5]. The fructooligosaccharides (FOS) and inulin found in plant foods 
belong to fructans. The Andean yacon plant contains high levels of these compounds in the 
roots, while the leaves have high amounts of flavonoids, phenolic acids, and tryptophan. 
These components are able to stimulate immune defense by exercising antioxidant, anti-
inflammatory, antimicrobial, and anticancer effects [6,7,8]. 
The ingestion of FOS and inulin modulate key physiological functions such as 
calcium absorption, lipid metabolism, and modification of intestinal microbiota [9]. The 
growth of bifidogenic bacteria following FOS and inulin consumption, which inhibit the 
establishment of pathogenic and/or putrefactive bacteria, is directly related to colon cancer 
prevention in experimental models [10]. Similarly, it has been reported that these 
compounds promote increased resistance to infections and reduce allergies [11,12].  
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The immunomodulatory potential of the functional substances contained in the yacon 
root is not yet fully understood. This study aims to evaluate the physiological and 
immunological effects resulting from incorporating yacon flour in the diet of young mice. 
 
2. Materials and Methods 
2.1. Animals 
Female mice from the BALB/c strain, aged 8 weeks, were obtained from the 
Multidisciplinary Center for Biological Research (CEMIB) at UNICAMP and were 
maintained throughout the experimental phase in specific pathogen free (SPF) conditions. 
The mice were housed in metabolic cages with a light/dark cycle of 12 hours at a 
temperature 22 ± 2°C. The mice were given water and food ad libitum. Ethics Committee 
in the use of animals at UNICAMP (CEUA) approved this research protocol under license 
1659-2. 
2.2. Yacon 
Yacon roots, cultivated in São Paulo, Brazil, were acquired at the CEASA market in 
Campinas, Brazil. The slices of yacon were frozen at -40°C and lyophilized at 40°C and 
500 µHg during 12 h (LP 1010; Liobras, São Carlos, Brazil) and then they were milled. 
Quantitative analyses were performed for proximate characterization of the lyophilized 
yacon, including determination of the protein, fat, carbohydrate, ash, fiber and water 
contents. The FOS content was determined by high-performance liquid chromatography 
(HPLC) using a Dionex Ion Chromatograph Model ICS-3000 (USA). 
Fructooligosaccharides were identified by the refraction index and categorized by 
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comparison with the retention standard of 1-kestose patterns (GF2), nystose (GF3) and 
fructofuranosyl nystose (GF4). Proteins were measured using the micro-Kjeldahl method 
[13]. The Bligh and Dyer method [14] was used to determine the lipid content. The crude 
fiber determination was made using the Scharrer & Akurschner method [15]. The moisture 
and ash contents were determined gravimetrically [16].  
2.3. Diets and experimental groups 
The basic maintenance diet was prepared according to the Reeves and collaborators 
[17] guidelines. For preparation of the diets containing FOS, the sucrose in the basic diet 
was replaced by lyophilized yacon flour containing 3% or 5% of FOS or 5% commercial 
FOS. Table 1 illustrates the final formulation of the diets.  
Mice were divided into four experimental groups receiving the specified diets for 30 
consecutive days. The control group (G1): AIN93M standard diet. Group 2 (G2): standard 
diet supplemented with 5% commercial FOS (Corn Products Brasil-Industrial Ingredients 
Ltda., São Paulo, Brazil). Group 3 (G3): standard diet plus yacon flour containing 3% FOS. 
Group 4 (G4): standard diet plus yacon flour containing 5% FOS. Feed consumption and 
the mice's weights were monitored weekly. 
2.4. Serum and feces samples  
Thirty days after receiving the specified diets, mice were bled; sera were individually 
separated and maintained at -20oC until use. Feces were individually collected and 
resuspended in PBS, 0.2 M, pH 7.4, at a 1:3 (w/v) ratio, vortex stirred and centrifuged at 
200g for 10 min. The feces extracts and sera were immediately used in ELISA assays to 
detection of antibodies. 
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2.5. Macrophage cultures 
Peritoneal macrophages were isolated from mice previously stimulated 
intraperitoneally with 3% thioglycollate (DIFCO, Franklin Lakes, NJ, USA) and cultured 
as indicated elsewhere [18]. The suspensions were adjusted to a concentration of 1x106 
cells/mL in complete medium [RPMI 140 (Sigma) containing 10% FBS (Nutricel) and 
antibiotics (Sigma)]. Aliquots of 1 mL were plated in each well of 24 well plates (Corning) 
and incubated for 2 hours at 37oC with 5% CO2. After removal of non-adherent cells, 
monolayers were incubated with LPS (1.0µg /mL) and IFN-γ (150 IU/ml) for 48 hours. 
Cells cultured in complete medium alone were used as controls. The culture supernatants 
were used to evaluate NO and cytokine production. 
2.6. T lymphocyte proliferation 
Proliferation assays were performed as indicated elsewhere [19]. Spleens were 
individually collected to prepare suspensions of erythrocyte free splenic cells. The cells 
were re-suspended in complete RPMI 1640 in 96-well plates (Corning) at a density of 
2.5x105 cells per well and incubated for 48 hours at 37oC and 5% of CO2 in the presence of 
2.5 µg/mL Concanavalin A (Con-A, Sigma, USA). The supernatants were collected and 
stored at -80oC for cytokine dosages. Cell proliferation was assessed by the MTT method 
(4.5 -Dimethyl-2 thiazolyl-2,5-diphenyl-2H-tetrazolium bromide) read at 540 nm following 
formazan crystal dissolution. All samples were analyzed in sextuplicate. The absorbency 
results obtained from each treatment were expressed as ± SEM (Standard Error of the 
Mean) averages. 
 
 97 
 
2.7. Flow cytometry analysis 
To block nonspecific reactions, the cell suspensions (106 cells) were initially 
incubated with culture supernatant from clone 2.4G2 (anti-CD16/32), prepared in our 
laboratory. Then, cells were stained with either specific monoclonal antibodies or with the 
control isotypes, according to the manufacturer’s recommendations (eBiosciense; San 
Diego, CA. USA). Finally, the cells were re-suspended in 500µL of PBS containing 1% 
formaldehyde. The following antibodies were used: anti-CD3 (Clone 2C11, labeled with 
Percp-Cy5.5 or PE), anti-CD4 (clone GK1.5, rat IgG2b, labeled with FITC), anti-CD8 (in 
conjunction with PE clone 53-6.7, and rat IgG2), and anti-CD19 (clone 1D3, rat IgG2a 
kappa labeled with PE-Cy5.5). Rat IgG2 and IgG2b, labeled with PE, FITC or PE-Cy5.5 
were used as isotopic controls. The preparations were analyzed using a FACS-Aria flow 
cytometer (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) located at the 
UNICAMP's Hematology Center. The event analyses were performed using FACSDIVA 
software (Becton, Dickinson and Company, Franklin Lakes, NJ, USA).  
2.8. Cytokine measurement 
Cytokines IFN-γ, IL-4, IL-1β, IL-10 (eBioscience; San Diego, CA. USA) and TNF-α 
(OptEIA, BD Biosciences; San Diego, CA. USA) were measured by ELISA in the culture 
supernatants using commercial kits, following the manufacturers' guidelines.  
2.9. Detection of serum and fecal antibodies  
Serum concentrations of IgM, IgG and IgA and fecal concentrations of IgA were 
measured by a capture ELISA developed in our laboratory, using commercially available 
antibodies (Sigma). 96-well microtitration plates (Nunc, Roskilde, Denmark) were coated 
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with a solution of polyclonal anti-murine immunoglobulin antibodies produced in goat, 
diluted in carbonate/sodium bicarbonate buffer, 0.1 M, pH 9.6. The plates were incubated 
overnight at 4°C and washed with PBS at 0.2 M, pH 7.4, containing 0.05% Tween 20. The 
free sites were blocked and the plates washed as above. The supernatant was used for fecal 
IgA detection. The serum and feces samples were added to the wells at various dilutions, 
and the plates were incubated for 1 h at 37°C. After washing, the specific anti-IgG, anti-
IgM or anti-IgA antibodies were tagged with HRPO and added at predetermined dilutions. 
The reaction was developed by adding the chromogen substrate (0.03% H2O2 and 0.04% 
orthophenylenediamine in citrate-phosphate buffer, 0.05 M, pH 5.5) followed by incubation 
in the dark for 15 min. The reaction was stopped by adding 4 N H2SO4 to each well. The 
absorbance was read in a microplate reader (Multiskan MS, Labsystems, Helsinki, Finland) 
at a wavelength of 492 nm. The average concentrations of each immunoglobulin tested 
were calculated with a standard curve prepared with purified IgM, IgG and IgA (Sigma). 
2.10. Nitric oxide measurement 
Nitrite was measured using the Green specifications [20]. Briefly, aliquots of 50 µl 
Griess reagent (1% sulphanilamide in 5% phosphoric acid and 0.1% naftilethylenediamine 
dihydrochloride in distilled water) were added to identical volumes of supernatants from 
cultures of macrophages, distributed previously in 96-well plates. After a 15 min incubation 
followed by plate agitation, the readings were performed in a spectrophotometric ELISA 
reader at 540 nm using sodium nitrite solutions (5 at 320 µM) as standards. The results 
were expressed in µM nitrite/1x10
6
 cells/mL. 
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2.11. Statistical analysis 
Statistical analysis on the results was performed using the ANOVA analysis of 
variance followed by Bonferroni´s test using GraphPadPrism software. The minimum 
probability acceptable for differences between the averages was considered to be p≤0.05. 
 
3. Results 
3.1. Chemical composition of yacon flour and experimental diets 
The results of the proximate analyses of the lyophilized yacon flour revealed a high 
carbohydrate proportion (86.13 %), proteins (2,45 ± 0,09%), lipids (0,87 ± 0,10%), ash 
(2,53 ± 0,14%), moisture (8,02 ± 0,08%), and crude fiber (3,46 ± 0,12%). The 
chromatography analyses by HPLC identified the presence of sugars such as glucose (7.3 ± 
0,59 %), fructose (14.1 ± 0,41 %), and sucrose (10.5 ± 0,45 %). The fructooligosaccharides 
GF2-GF4 accounted for 34.31± 1.63% of the sugars present in the mixture. Based on these 
findings, diets were prepared in which the sucrose content normally present in AIN93M 
was replaced by either 5% commercial FOS or 3% or 5% yacon FOS. The proximate 
analysis of these diets revealed no significant differences in their chemical compositions. 
However, the diets that included 3% or 5% yacon FOS had 8 kcal less sugar than the 
control diet (Table 2).  
3.2. Food intake, body weight 
The dietary intake of FOS-supplemented diets and the BALB/c mice’s weights were 
evaluated by weekly weighing (Figure 1). There was no significant difference between the 
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weekly consumption of rations supplemented with FOS and the standard diet (Fig. 1 C). 
Similarly, mice fed a diet supplemented with FOS showed no significant variation in 
weight compared to control mice (Figure 1 A, B). 
3.3. Levels of serum IgM, IgG, and IgA and fecal IgA 
The levels of antibodies in serum and stool were analyzed in samples collected from 
mice fed either a diet containing FOS or a standard diet (Figure 2). There were no 
significant differences in serum IgG and IgA levels (Figure 2A, B), but there was a slight 
but statistically significant decrease in serum IgM in mice fed a diet containing 3% yacon 
FOS (Fig 2C). Fecal sample analysis showed a significant increase in the amount of IgA in 
samples collected from mice fed diets containing yacon FOS (Fig 2D). 
3.4. Effects of yacon on the frequency and activation of lymphocytes  
To verify the influence of yacon consumption on the peripheral distribution of T and 
B-lymphocytes, blood cells and spleens of mice fed with either the standard diet or the diets 
containing FOS were collected thirty days after the start of the experiment for analysis by 
flow cytometry. The results illustrated in Figure 3 show no significant differences in the 
proportions of these cell populations in either the blood (Figure 3A) or the spleen (Figure 
3B) between the groups.  
ConA-induced proliferation in splenic T lymphocytes was significantly higher in 
mice fed a diet containing yacon FOS than that observed in cells from mice fed a standard 
diet (Figure 3C). Following these findings, we observed a slight but significant increase in 
IFN-γ secretion in the cultures of spleen cells from mice fed 3% yacon FOS. There were no 
significant differences in IL-4 secretion observed (Figure 3 D, E). 
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3.5. Effects of yacon on peritoneal macrophage iNOS activity and cytokine production  
To evaluate the possible effects of yacon FOS ingestion on peritoneal macrophage 
activity, iNOS and the cytokines IL-1β, TNF-α, and IL-10 were measured in supernatants 
from thioglycollate-acquired macrophage cultures stimulated in vitro with LPS+IFN-γ. No 
significant changes in NO production were observed between macrophages obtained from 
the different dietary groups (Figure 4A). Similarly, no significant difference in IL-10 
secretion was identified. However, IL-1β secretion was found significantly reduced in the 
cells cultures derived from mice fed with rations containing either commercial or yacon 
FOS. 
 
4. Discussions 
According to Roberfroid and associates [21], prebiotic effects may be defined as “the 
selective stimulation of growth and/or activity (ies) of one or a limited number of microbial 
genus (era)/species in the gut microbiota that confer(s) health benefits to the host”. Thus, 
the incorporation of prebiotics in the diet leads to health benefits by changes in the gut's 
microbiota composition, especially an increase of the fecal concentrations of the 
bifidobacteria. The presence of healthy intestinal microbiota promotes a state of immune 
tolerance, which prevents the elimination of commensals and antigenic organisms from the 
diet, food allergies, and bowel disorders such as irritable bowel syndrome. Moreover, the 
consumption of prebiotics improves stool quality as measured by pH, SCFA, frequency and 
consistency, reduces the risk of infections and gastroenteritis, and increases Ca absorption, 
bone calcium accretion, and bone mineral density [9,22]. As observed in this study, yacon 
root flour contains reduced quantities of glucose and sucrose and high levels of FOS, which 
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is found in higher proportion in the yacon than in either chicory or Jerusalem artichokes 
(22.9/100 g and 13.5/100 g, respectively) [23,24]. Recent studies have shown positive 
effects resulting from yacon consumption. In adult women (31-49 years of age) with mild 
obesity and dyslipidemia, consumption of 0.14 or 0.29 g FOS/kg body weight over 120 
days, resulted in decreased body weight, body mass index, and serum insulin, in addition to 
increased frequency of defecation and feelings of satiety [25]. The consumption of yacon 
flour containing 5% or 7% FOS for 27 days increased calcium absorption in Wistar rats, as 
well as an increase in the depth and number of intestinal crypts [26]. Habid and associates 
[27] showed hypolipidemic effects in diabetic Wistar rats that consumed yacon flour 
containing 340 or 6,800 mg FOS/kg body weight/d for 90 days. These effects on lipid 
metabolism were correlated with an increase in insulin-positive pancreatic cells within the 
exocrine parenchyma, although only a slight increase in plasma insulin levels was 
observed.  
The partial or complete replacement of sucrose by the yacon flour in the diet resulted 
in similar levels of food intake and body weight as those observed in mice fed a standard 
diet. Similar observations have been reported in other experiments using diets 
supplemented with FOS [4,28]. The consumption of FOS (0.20 g /day/mouse) over 24 days 
by older female C57Bl/6J mice (33 to 35 weeks of age) from the second generation of mice 
fed with a diet poor in n-3-polyunsaturated fatty acids resulted in weight gain and better 
utilization of nutrients compared to the group fed a control diet [29].  
In our study, we observed that the intake of a diet supplemented with commercial or 
yacon FOS resulted in no changes in serum levels of IgG and IgA. Literature data show that 
normal levels of IgM in sera of Balb/c mice are between 1.1 and 1.3 mg/mL [30]. In our 
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study, we found IgM levels ranging from 2.39 (± 0.149) and 1.73(± 0.097) mg/mL. Thus, 
although statistically significant, the diference in serum IgM levels observed between 3% 
yacon FOS and control groups seems to have no biological significance.  However, the 
amount of fecal IgA was significantly higher in these groups compared to mice fed a 
standard diet. Hosono and associates showed that BALB/c mice, when fed 2.5% FOS, had 
increased fecal IgA levels as well as increased secretion of IgA by lymphocytes from the 
Peyer's patches of mice fed 2.5 % or 7% FOS, which were then cultured in bacterial extract 
[31]. Likewise, it was observed that the consumption of 5% FOS raised IgA levels in 
intestinal tissues extracts [32]. Other prebiotics, such as cicloinulooligossacharides and 
isomaltooligosaccharides, have also been shown to increase fecal IgA levels in mice 
[33,34]. Conversely, inulin consumption did not significantly alter the levels of fecal IgA in 
mice [12].  
The IgA can function as a high affinity system to neutralize toxins and pathogenic 
microorganisms or as a low affinity process to contain the dense microbiota content of the 
intestinal lumen [35]. Diets enriched in FOS and inulin can provoke and stimulate the 
intestine's mucosal immune system, and may improve the efficacy of vaccines administered 
orally [36]. In this study, we found increased fecal IgA in mice fed FOS in the absence of 
specific antigenic stimuli, which may be involved in the fixation of commensal 
microorganisms in the intestinal lumen.  
Although we did not observe any diet-related changes in the frequency of T and B 
cells in the blood or spleen, our results showed that splenic lymphocytes from mice fed 
diets containing yacon FOS were more responsive to the ConA, in terms of proliferative 
response. Lymphocytes from mice fed AIN93-3% yacon also presented a more elevated 
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production of IL-4 and IFN-γ than splenic lymphocytes from mice fed the standard diet, 
although differences were statistically significant to IFN-γ. Thus, it seems to us there was 
no biological significance in these differences.  
Despite of macrophages from mice fed FOS produced low levels of IL-1β in response 
to in vitro stimulation with LPS, the levels of TNF-α where slightly more elevated in those 
groups. In consequence, no alterations in NO and IL-10 levels could be observed in 
macropahges supernatants, thus indicanting a balanced production of pro- and anti-
inflamatory mediators in macrophages by the consumption of yacon.  
Several studies convey the importance of healthy microbiota in maintaining the 
intestinal tract's physiological and immunological functions, including inducing 
tolerogenesis toward exogenous antigens, such as those present in the diet [37]. The 
immune response against pathogens is characterized by the recognition of molecular 
patterns combined with strong innate responses, followed by an adaptive response to 
eliminate the offending agent, which often results in damage to the host's tissues. The 
response toward components of the symbiotic microbiota, however, is characterized by a 
complex integrated system of microbial recognition and inhibition of immune effector 
activation [38]. This process involves both the maintenance of a significant number of 
macrophages and dendritic cells in a state of immaturity and an appropriate balance 
between regulatory T (Treg) lymphocytes and "inflammatory" T lymphocyte subsets, such 
as Th1 and Th17 [39]. Similarly, the levels of fecal antibodies play an important role in 
digestive tract homeostasis. IgA is only induced at high levels in the intestines of animals 
with intestinal microorganisms. In germ-free mice, the numbers of IgA-producing cells are 
decreased almost two times [38]. Our results showed that regular consumption of yacon 
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FOS by mice presents no adverse effects and not alter the peripheral immune system 
balance, as well as encourage the production of intestinal IgA. Despite of yacon is being 
used in folk medicine for long time, well-designed clinical studies testing the effects of 
regular yacon consumption in humans are still necessary.  
 
5. Conclusions 
Our results show that regular consumption of yacon by BALB/c mice showed no 
adverse side effects to the whole-organism physiology, particularly to the immune system 
balance. This paper is the first to describe that consumption of yacon flour rich in FOS 
promotes increased levels of intestinal IgA. 
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Legends: 
Table 1.- Formulation of experimental diets. Four different diets were prepared as follow: 
A) AIN93M, control diet, (B) 5% FOS, (C) 3% yacon FOS, (D) 5% yacon FOS. In diets B, 
C, and D, sucrose was replaced by FOS or yacon flour. For diet D, the starch was also 
replaced. 
 
Table 2.- Chemical composition of the experimental diets. The four diets were 
gravimetrically analyzed for moisture, ash, and total solids contents. Protein was measured 
by the micro-Kjeldahl method [13], Total lipids were measured by the Bligh & Dyer 
method [14]. The calories were calculated using the conversion factor for proteins 4.0, 
carbohydrates 4.0, and lipids 9.0. 
 
Figure 1.- The effects of regular yacon consumption on weight of BALB/c mice: A) The 
average weekly consumption during the trial period was evaluated. B) The mouse weight 
was monitored weekly, during the diet intake. C) The percentage of weight gain variations, 
relative to the start of feeding. Data were analyzed using the ANOVA analysis of variance 
followed by the Bonferroni´s test in comparison with the group that consumed AIN93 in 
the same period. Values of p≤0.05 (*) were considered significant (n=18). 
 
Figure 2.- The effects of regular yacon consumption on the antibody levels in serum and 
feces. A-C) Serum IgG, IgM, IgA and fecal IgA, respectively. The data collected were then 
analyzed by the ANOVA analysis of variance followed by Bonferroni´s test, with values 
p≤0.05 considered significant. (*) represents p≤0.05 compared with the AIN93M group 
(n=6). The data are representative of two independent experiments. 
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Figure 3.- The effect of regular yacon consumption on peripheral immune system. A) T 
and B-lymphocyte frequency in peripheral blood. B) T and B-lymphocyte frequency in 
spleen. C) Con-A induced proliferation of spleen cells. D-E) Levels of IL-4 and IFN-γ in 
culture supernatants. Statistical analysis was conducted using the ANOVA analysis of 
variance followed by Bonferroni´s test, with values of p≤0.05 considered significant (n=6). 
(*) represents p≤0.05 compared with the AIN93M group, and (#) represents p≤0.05 when 
compared with the FOS group. 
 
Figure 4.- The effects of the regular yacon consumption on NO and cytokine production by 
in vitro stimulated peritoneal macrophages. A) NO production, as measured by MTT 
method. B-D) Levels of IL-1β, TNF-α and IL-10, respectively. Statistical analysis was 
conducted using the ANOVA analysis of variance followed by Bonferroni´s test. Values of 
p≤0.05 were considered significant (n=6). (*) represents p≤0.05 compared with the 
AIN93M group, and (#) represents p≤0.05 compared with the FOS group. 
 113 
 
Tables: 
Ingredients (g/Kg) AIN 93M FOS 5% YACON 3% YACON 5% 
Cornstarch 465, 69 465, 69 465, 69 425, 69 
Casein (>= 85%) 140,0 140,0 140,0 140,0 
Dextrinized cornstarch 155,0 155,0 155,0 155,0 
Sucrose 100,0 52,5 7,0 0,0 
FOS 0,0 47,5 0,0 0,0 
Yacon root  0,0 0,0 93,0 140,0 
Soybean oil (no additives) 40,0 40,0 40,0 40,0 
Fiber 50,0 50,0 50,0 50,0 
Mineral mix 35,0 35,0 35,0 35,0 
Vitamin mix 10,0 10,0 10,0 10,0 
L-cystine 1,8 1,8 1,8 1,8 
Choline bitartrato 2,5 2,5 2,5 2,5 
Tert-butylhidroquinona 0,008 0,008 0,008 0,008 
 
Table 1 
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Components AIN93M FOS 5% YACON 3% YACON 5% 
Moisture 8,02±0,28  8,13±0,53 9,85±0,48 9,60±0,00 
Total Solids 91,98±0,28  91,87±0,53 90,15±0,48 90,40±0,00 
Protein  11,48±0,31  11,47±0,03 13,08±0,77 12,11±0,12 
Lipids  4,27±0,13  4,09±0,20 4,53±0,13 4,18±0,08 
Ash 2,62±0,10  2,68±0,05 3,12±0,17 2,93±0,18 
Carbohydrate 73,61 73,63 69,42 71,19 
Energy Kcal /100g 378,78 377,19 370,78 370,77 
 
Table 2 
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CAPÍTULO 5 
THE EFFECTS OF THE REGULAR INTAKE OF YACON ROOT (Smallanthus 
sonchifolius) ON TNBS-INDUCED COLITIS IN MICE  
 
 
Grethel T. Choque Delgadoa, Rodolfo Thoméb, Wirla M.S.C. Tamashirob, Glaucia M. 
Pastorea. 
 
aDepartment of Food Science, School of Food Engineering, University of Campinas, P.O. 
Box 6121, 13083-862, Campinas, São Paulo, Brazil. 
bDepartment of Genetics, Evolution and Bioagents, Institute of Biology, University of 
Campinas, P.O. Box 6109, 13083-862, Campinas, São Paulo, Brazil. 
 
 
 
 
 
 
 
 
 
 
This manuscript was submitted to Plant Foods for Human Nutrition.
 120 
 
Abstract 
Fructooligosaccharides (FOS) have been shown to improve intestinal function, 
increase resistance against pathogens and promote immunomodulation. The yacon root 
contains a high content of FOS and inulin. The aim of this study was to evaluate the effects 
resulting from the incorporation of yacon flour into the diet of mice with TNB-induced 
colitis. Six-week-old female BALB/c mice were fed (1) the control diet AIN-93M, (2) a 5% 
commercial FOS diet and (3) a 5% yacon FOS diet. Thirty days later, half of each group 
was challenged by the intrarectal administration of TNBS, while the others received vehicle 
(ethanol). The mice challenged with TNBS and fed a diet containing 5% yacon FOS 
suffered significantly less weight loss compared to animals fed the control diet or 
commercial FOS. Spleen T lymphocytes of mice with colitis did not respond to TNBS in 
vitro. The intake of the AIN93M, FOS and yacon diets did not induce significant changes 
in Con-A induced T cell proliferation. The production of the cytokines TNF-α and IFN-γ by 
these cultures was high in all experimental groups. IL-17 was increased in groups fed FOS, 
while IL-10 was lower. The macroscopic and histological analysis of sections of the large 
intestine from yacon FOS-fed mice with colitis showed a lower degree of inflammation and 
better preservation of the structure of the intestinal wall in comparison with the other 
groups. Altogether, our data indicate that the regular consumption of yacon FOS results in 
the moderate protection of the mouse mucosal immune system against inflammatory 
agents. 
Keywords: yacon root (Smallanthus sonchifolius), (FOS), colitis, mucosa, IBD. 
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1. Introduction 
The mucosal immune system is continuously exposed to massive amounts of foreign 
antigens derived from microbes and the diet. This environment is usually a non-
inflammatory Th2 type, as evidenced by the predominance of IgA and IgG and the 
secretion of the cytokines IL-4, IL-10 and TGF-β by NKT cells and intestinal epithelial 
cells [1]. In contrast to the peripheral immune system, the microenvironment of mucosal 
surfaces inhibits the development of inflammatory immune responses in a scenario where 
the tolerance of foreign materials is the norm rather than the exception [2]. 
Breaking of tolerance to microbial antigens has been identified as one of the main 
factors leading to the development of intestinal disorders such as Crohn's disease and 
ulcerative colitis, which are collectively called Inflammatory bowel disease (IBD) [1,3]. 
The reduced expression of junction proteins and increased apoptosis of epithelial cells, 
which allows luminal antigens derived from non-pathogenic microorganisms to come into 
contact with cells of the mucosal immune system, have also been implicated in the 
pathogenesis of colitis [4-6]. The activation of dendritic cells (DCs) by flagellin derived 
from commensal bacteria appears to be one of the initial events in the development of IBD 
in humans and experimental models [7]. The activation of DCs via Toll like receptors 
results in the increased production of inflammatory cytokines such as TNF-α and a 
reduction in the regulatory cytokines normally present in this microenvironment, such as 
TGF-β and IL-10. Consequently, there is a marked reduction in the number of regulatory T 
cells from the CD4+ CD25+ Foxp3+ subpopulation, which favors the formation installation 
of an inflammatory environment [8,9]. 
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The conventional therapeutic approaches for IBD involve the use of drugs that down-
regulate the immune system, such as corticosteroids, aminosalicylates, azathioprine or 
infliximab (anti-TNF-α) [6,10]. 
Recently, new therapeutic approaches for IBD that include the consumption of 
probiotics [11], prebiotics [12-14] and symbiotics [15] have shown promising results. The 
aim of these therapies is the manipulation of the intestinal microbiota into a more 
appropriate profile with regard to the diversity of species and products derived from 
microbial metabolism [16]. 
Prebiotics like FOS and inulin have shown a more immediate potential therapeutic 
use [17]. It has been observed that the consumption of these compounds leads to an 
increase in bifidobacteria in the intestinal tract, with beneficial consequences for the 
mucosal immune system [18,19]. FOS/inulin is present in high amounts in many plants 
used as food, such as chicory, Jerusalem artichokes, asparagus, honey, onions, garlic, 
barley and bananas, among others [20-22]. The yacon, a root used in traditional Andean 
medicine for the prevention of diabetes and metabolic syndrome, also represents an 
abundant source of FOS/inulin [23,24]. 
The literature, however, lacks studies on the effects that the regular consumption of 
yacon has on the immune system in inflammatory conditions of the intestinal tract, such as 
IBD. This manuscript aims to evaluate the physiological and immunological effects of 
regular consumption of yacon on TNBS-induced colitis in young mice. 
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2. Material and Methods  
 
2.1. Animals 
Female BALB/c mice were obtained from the Multidisciplinary Center for Biological 
Research (CEMIB) at UNICAMP. The animals were housed in metabolic cages and were 
kept under specific pathogen free (SPF) conditions with a light / dark cycle of 12 hours, 
temperature of 22 ± 2°C and water and food ad libitum. The experimental protocols were 
approved by the Ethics Committee on the Use of Animals (CEUA), UNICAMP, under no. 
1659-2. 
 
2.2. Yacon 
The roots of yacon were grown in the region of São Paulo, Brazil, and subjected to 
freeze-drying and grinding to obtain the flour that was maintained at -80oC until use. The 
chemical composition of yacon flour was similar to that reported previously [25]. 
 
2.3. Diets  
The control AIN93 maintenance diet was prepared according to the specifications of 
Reeves and colleagues [26]. In the experimental diets, sucrose and starch were replaced by 
FOS or yacon flour, as described previously [25]. Six-week-old BALB/c mice were divided 
into the following groups (n = 12): (1) control diet AIN93M; (2) 5% commercial FOS diet 
and; (3) 5% yacon FOS diet. Mice were fed with these diets for 4 weeks before the 
induction of colitis. 
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2.4. Induction of colitis 
Colitis was induced in 10-week-old BALB/c mice according to Neurath and 
colleagues [27] with modifications. Briefly, half of each group of mice was challenged by 
the rectal administration of 0.5mg TNBS/100µl 50% ethanol, and the other half received 
only the vehicle (100µl 50% ethanol) for seven consecutive days. The food intake and 
weight of the mice were monitored weekly for the four weeks before the induction of colitis 
and daily for seven days after the induction of colitis.  
 
2.5. T lymphocyte proliferation 
The spleens were collected individually for the preparation of erythrocyte-free cell 
suspensions. The cells were resuspended in RPMI medium with 10% fetal bovine serum, 
seeded into 96-well plates (Corning, MA, USA) at a density of 2.5 x 105 cells per well and 
incubated for 48 hours at 37°C and 5% CO2 in the presence of 2.5µg/mL Concanavalin A 
(Con-A, Sigma, USA) or 50µg/mL TNBS-ovalbumin (OVA) previously prepared in our 
laboratory [28]. After incubation, the supernatants were collected and stored at -80°C for 
cytokine analysis. Cell proliferation was determined by the addition of MTT (3-[4, 5-
dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide) to the cultures. After the 
dissolution of formazan crystals, the plates were read in a spectrophotometer at 540nm. All 
tests were performed in sextuplicate. The proliferation results were expressed as the mean ± 
SEM absorbance obtained for each treatment. 
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2.6. Cytokine measurement 
IFN-γ, IL-4, IL-10, IL-17 (eBioscience; San Diego, CA. USA) and TNF-α (OptEIA, 
BD Biosciences; San Diego, CA. USA) were quantified by ELISA using commercial kits 
according to the manufacturer's instructions.  
 
2.7. Histological analysis 
The intestines were removed, sectioned in the region of the cecum and photographed. 
The intestinal segments were fixed in 1% buffered paraformaldehyde, embedded in 
paraffin, cut using a microtome (cutting thickness of 6µm) and stained with 
hematoxylin/eosin (H/E) for histopathological analysis.  
 
2.8. Statistical analysis 
The experimental data were analyzed using ANOVA followed by Bonferroni’s test. 
Analyses were performed with GraphPadPrism software, with p≤0.05 considered 
statistically significant. 
 
3. Results and Discussion  
TNBS-induced colitis is an experimental model that mimics many inflammatory 
events observed in human diseases such as ulcerative colitis and Crohn's disease. It is 
characterized by weight loss, bloody diarrhea and disorganization of the intestinal 
architecture [29,30]. FOS oligosaccharides are well known for their beneficial effects on 
the body, particularly on the composition of intestinal microbiota and the modulation of the 
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mucosal immune system [18,31]. Recent evidence has shown that these compounds play an 
important role in preventing the clinical manifestations of experimental colitis [32,33]. In a 
previous study, we showed that substituting the sucrose and starch in the standard diet with 
an equivalent amount of yacon FOS showed no significant alterations in weight gain and 
the humoral immune responses associated with the intestinal mucosa [25]. Data obtained in 
this work confirm our initial findings, as BALB/c mice fed a diet containing commercial or 
yacon FOS had food intake and weight gain levels comparable to those of animals fed the 
standard AIN93M diet (Fig. 1). Colitic mice fed either the standard diet or commercial FOS 
showed an accentuated loss of weigth, whereas those fed yacon FOS showed no alteration 
in comparison with animals in control group (Fig. 2B and C). Ribeiro [34] showed that the 
yacon meal contains high levels of phenolic acids, and is well known that phenolic 
compounds may act synergistically with FOS to produce its beneficial effects. Thus, the 
association between FOS and fenolic compound in yacon flour may be responsible for the 
protection against cachexia observed in those group of mice fed diet containg yacon. 
Macroscopic examination of intestinal pieces shows that yacon-based diets seem to 
protect mice against TNBS-induced inflammation as characterized by the absence of 
bloody feces, integrity of intestinal walls and formation of stool. The intestines of mice fed 
yacon FOS showed no infiltrating leukocytes, as opposed to what we observed in the 
intestines of mice that consumed the standard diet or commercial FOS. The epithelial layer 
of the large intestine of mice fed a diet including yacon was also better preserved than the 
epithelial layers in the other groups with colitis (Fig. 2A). The benefits of prebiotic 
consumption have been attributed to the way in which these compounds are metabolized in 
the intestinal tract [35]. It has been shown that the ingestion of such food favors an increase 
in the proportion of symbiotic bacteria such as lactobacillus and bifidobacterium, which 
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produce short chain fatty acids specially butyrate, in the intestinal flora [36,37]. The 
metabolites produced by these intestinal bacteria play an important role in the intestinal 
mucosal immune system, favoring the development of an environment that inhibits 
inflammatory responses [38,39]. The destruction of the epithelial layer of the intestinal 
mucosa is an important element in the establishment of colitis in both humans and 
experimental models [1,2]. It is possible that the protection against the establishment of a 
more severe TNBS-induced colitis in yacon-fed mice may due to a prebiotic effect of 
yacon. In previous study, we observe an elevation of the levels of fecal IgA in absence of 
infection and inflammation that support this idea [25]. New researchs, however, are 
necessary to determine the effects that regular yacon consumption has on the intestinal 
microbiota and their products in both mice and humans. 
To assess the systemic effects of FOS and yacon consumption on the adaptive 
immune response, spleen cells were stimulated with ConA or TNBS to determine cell 
proliferation and the production of pro- and anti-inflammatory cytokines. Figures 3 and 4 
summarize the results obtained in these experiments. These figures show that stimulating 
splenic lymphocytes with TNBS did not cause spleen cells from any of the experimental 
groups to proliferate (Fig. 3A). Likewise, pro- and anti-inflammatory cytokine levels in 
these cultures did not differ significantly from unstimulated cultures of spleen cells from 
mice fed standard diet or a diet containing commercial FOS (Fig. 3B-F).  However, TNF-α 
and IFN-γ were found augmented in the supernatants of TNBS-stimulated cultures of 
spleen cells from mice fed yacon FOS. It has been shown that TNBS-induced colitis in 
BALB/c mice is a Th2 model of the disease, and sometimes a mix Th2/Th1 model. The 
balance of Th2/Th1 response may be related to the contribuition of normal microbiota and 
its mitogens (LPS, CpGs, etc) in activation or not of the IL-12 pathway in antigen 
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presenting cells [2]. However, consumption of yacon favors the imbalance between 
Th2/Th1 responses with the predominance of a Th1 response. On the other hand, IL-17 that 
now has been implicated as the main responsible for damages in bowel diseases [40] was 
not significantly altered by consumption of FOS. 
The regular consumption of commercial FOS and yacon FOS did not affect the 
proliferative capacity of T lymphocytes in response to ConA, showing that cells from 
different experimental groups of mice were equally responsive to non-specific stimulation 
(Fig. 4A). However, stimulation with ConA resulted in the increased production of Th1-
type cytokines (TNF-α and IFN-γ) in the cultures of spleen cells from all experimental 
groups, regardless of the diet consumed (Fig. 4B and C). Surprisingly, IL-17 production 
was significantly higher in the cultures of splenocytes from mice fed FOS (Fig. 4D). 
Moreover, the production of IL-10 was lower in the cultures of cells isolated from mice fed 
a diet containing commercial FOS or yacon FOS (Fig. 4F). Arribas and colleagues [32] also 
found that the consumption of FOS protects against the deleterious effects of TNBS-
induced colitis. However, the effect observed by these authors was associated with reduced 
levels of colonic pro-inflammatory cytokines, myeloperoxidase and nitric oxide. The 
contradictory results we obtained may be attributed to the source of cells used in the study. 
Further studies are essential to clarify the interference of yacon consumption on the 
intestinal immune response, particularly in lymphocytes from intestinal sites such as 
mesenteric lymph nodes, Peyer´s patches and lamina propria. 
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5. Conclusion  
Taken together, our data show that the regular consumption of yacon FOS reduces the 
clinical signs of colitis in mice by mechanisms that remain to be elucidated but may be 
related to changes in the microbiota and the cell response profile in the intestinal 
microenvironment. 
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Legends: 
Figure 1.- The effects of regular yacon consumption on body weight and food intake. Six-
week-old BALB/c mice (n=12) consumed diets containing 5% commercial FOS, 5% yacon 
FOS or a control diet (AIN-93M) for thirty consecutive days. The results were analyzed 
using ANOVA followed by Bonferroni’s test. P values ≤0.05 (*) in comparison with the 
group that consumed AIN93M were considered significant. 
 
Figure 2.- Effects of regular consumption of yacon on clinical signs of colitis. Six-week-
old BALB/c mice (n=12) consumed diets containing 5% commercial FOS, 5% yacon FOS 
or a control diet (AIN-93M) for thirty consecutive days. For the induction of colitis, half of 
each group of mice was immunized and challenged with 0.5 mg TNBS/100µl 50% ethanol 
per rectum, while the controls received the vehicle (ethanol) for seven consecutive days. A) 
Macroscopic and histological evaluation of the large bowel (intestines were dissected, fixed 
in paraformaldehyde, embedded in paraffin and processed for histological analysis with 
H/E). Magnification: 400X . B-C) Body weights at the week of colitis induction and at the 
end of the experiment. Data were analyzed using ANOVA followed by Bonferroni’s test. P 
values ≤0.05 (*) in comparison with the group that consumed AIN93M were considered 
significant. 
 
Figure 3.- The proliferation and cytokine production of antigen-specific T cells. Six-week-
old BALB/c mice (n=12) consumed diets containing 5% commercial FOS, 5% yacon FOS 
or a control diet (AIN-93M) for thirty consecutive days. For the induction of colitis, half of 
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each group of mice was immunized and challenged with 0.5 mg TNBS/100µl 50% ethanol 
per rectum, while the controls received the vehicle (ethanol) for seven consecutive days. 
(A) At the end of the experiment, spleen cells were collected and placed in culture in the 
presence of a specific stimulus (50µg/mL TNBS-OVA). (B-F) The culture supernatants 
were collected and assayed for TNF-α, IFN-γ, IL-17, IL-4 and IL-10. Statistical analysis 
was performed by ANOVA followed by Bonferroni’s test. P values ≤0.05 were considered 
significant; (#) represents a p value ≤0.05 compared with the AIN93 group; (*) represents a 
p value≤0.05 compared with the baseline group (no stimulus). 
 
Figure 4.- The proliferation and cytokine production of T cells stimulated with ConA. Six-
week-old BALB/c mice (n=12) consumed diets containing 5% commercial FOS, 5% yacon 
FOS or a control diet (AIN-93M) for thirty consecutive days. For the induction of colitis, 
half of each group of mice was immunized and challenged with 0.5 mg TNBS/100µl 50% 
ethanol per rectum, while the controls received the vehicle (ethanol) for seven consecutive 
days. (A) At the end of the experiment, spleen cells were collected and placed in culture in 
the presence of 2.5µg/mL ConA. (BF) The culture supernatants were collected and assayed 
for TNF-α, IFN-γ, IL-17, IL-4 and IL-10. Statistical analysis was performed by ANOVA 
followed by Bonferroni test. P values ≤0.05 were consider significant; (#) represents a p 
value ≤0.05 compared with the AIN93M group; (*) represents a p value ≤0.05 compared 
with the baseline group (no stimulus). 
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CONCLUSÕES GERAIS 
Considerando que os frutanos de tipo inulina e frutooligosacarídeos agem como 
agentes bifidogênicos, nos propusemos neste trabalho a estudar o efeito do consumo regular 
de yacon sobre o sistema imune murino em condições fisiológicas e após a indução de 
doença inflamatória intestinal provocada pela administração de TNBS. 
Os resultados obtidos no presente estudo indicaram que: 
• O consumo regular de yacon não acarreta efeitos deletérios ao sistema imune murino. Os 
animais que consumiram dieta suplementada com FOS de yacon mantiveram os mesmos 
padrões de perfil celular, secreção de citocinas, níveis séricos de anticorpos e 
proliferação celular observados nos animais alimentados com dieta padrão; 
• O yacon parece possuir propriedades prebióticas, favorecendo a expansão de microbiota 
mais adequada, uma vez que o consumo de dieta contendo yacon levou à elevação dos 
níveis de IgA intestinal na ausência de infecção; 
• A alimentação com dieta contendo FOS de yacon previne pelo menos parcialmente o 
desenvolvimento de reações inflamatórias no trato intestinal. Camundongas alimentados 
com yacon tornaram-se menos susceptíveis ao desenvolvimento de sintomas clínicos da 
colite experimental induzida por TNBS, embora os parâmetros imunológicos não 
tenham sido completamente modulados. 
Desta forma, consideramos que o yacon possui grande potencial como alimento 
funcional devido a sua elevada concentração de FOS e inulina e pelos efeitos ora 
observados sobre o sistema imune em murinos. 
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SUGESTÕES DE PESQUISAS FUTURAS 
 
Os estudos de consumo de yacon em humanos são escassos e novas pesquisas são 
necessárias para avaliar seu potencial immunomodulador em uma situação de desafio, 
como nas doenças inflamatórias do trato intestinal. Ainda se faz necessário determinar as 
dosagens ótimas, durações de tratamento e os efeitos específicos de consumo de yacon em 
matrizes e populações diferentes, como infantes, idosos e imunosuprimidos. Além disso, é 
importante avaliar os efeitos do consumo regular de yacon sobre a composição da 
microbiota intestinal murina e humana. 
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ANEXO 1: Aprovação da Comissão de Ética no Uso de Animais 
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